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ABSTRACT 
 
A number of nanomaterials (NMs) have been applied in different fields due to their unique 
physico-chemical properties. As the use and applications have increased in some industries, serious 
concerns about their potential impact on the environment and the human health have been raised and 
have been a challenge for the regulatory authorities. 
This work aimed at assessing the toxicity of three classes of NMs, namely cerium dioxide, CeO2 
(NM-212), titanium dioxide, TiO2 (NM-101 and NM-100) and barium sulphate, BaSO4 (NM-220) since 
they already have a broad range of applications in industry and consumer products. 
A standardized protocol for NMs dispersion was followed and the quality of the dispersion in the 
culture medium was evaluated by the dynamic light scattering technique. Different concentrations (0, 1, 
3, 10, 30, 75 and 100 µg/cm2) of each nanomaterial were used to expose A549 cells (human lung 
carcinoma cells) for cytotoxic evaluation through the MTT and clonogenic assays and genotoxicity 
assessment through the comet and the cytokinesis-blocked micronucleus (CBMN) assays. 
The results showed a decrease in cell proliferation after exposure to cerium dioxide 
nanomaterials for 8 days, at the highest concentrations tested and a slight increase in the level of DNA 
breaks. Concerning the TiO2 NMs, a statistically significant increase in the level of DNA breaks was 
found for both NMs; however the CBMN assay did not show any increase in the frequency of 
chromosomal breaks. BaSO4 was the NM that showed the lowest toxicity in cyto- and genotoxicity 
assays. 
Even though the present results contribute to assess the hazard of the tested NMs, the real 
effects of nanomaterials’ exposure to human health are still unclear and an unequivocal conclusion is 
difficult to present, given the inconsistent and often conflicting results found in the literature. Thus, the 
application of some nanomaterials in consumer products should be carefully evaluated until definite 
conclusions about their safety are available. 
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RESUMO 
 
Diferentes nanomateriais têm sido aplicados em diferentes áreas, devido às suas propriedades 
físico-químicas únicas. Como o uso e as aplicações têm aumentado em algumas indústrias, os 
possíveis impactos no ambiente e na saúde humana têm sido questionadas e tem-se revelado um 
desafio as autoridades reguladoras. 
Este trabalho tem como objectivo avaliar a toxicidade de três classes de NMs, nomeadamente, 
dióxido de cério, CeO2 (NM-212), dióxido de titânio, TiO2 (NM-101 e NM-100) e sulfato de bário, BaSO4 
(NM-220), visto que estes já possuem uma vasta aplicação na indústria e em produtos de consumo. 
Foi seguido um protocolo padronizado para a dispersão dos nanomateriais e qualidade da 
dispersão no meio de cultura foi avaliada através da técnica de dynamic light scattering. Foram 
utilizadas diferentes concentrações (0, 1, 3, 10, 30, 75 e 100 µg/ cm2) de cada nanomaterial, para expor 
a cultura de células A549 (células de carcinoma de pulmão humano) para avaliação da citotoxicidade 
através dos ensaios do MTT e clonogénico e dos ensaios do cometa e dos micronúcleos para o estudo 
da genotoxicidade. 
Os resultados mostraram uma diminuição na proliferação de células após exposição aos 
nanomateriais de dióxido de cério, durante 8 dias, nas concentrações mais elevadas e um aumento 
ligeiro nas quebras do DNA. No que diz respeito ao TiO2 verificou-se um aumento estatisticamente 
significativo no nível de quebras de DNA para ambos os NMs, no entanto o ensaio dos micronúcleos 
não apresentou nenhum aumento na frequência de quebras cromossómicas. O BaSO4 foi o 
nanomaterial que apresentou menor toxicidade tanto nos ensaios de citotoxicicdade como 
genotoxicidade. 
Apesar dos presentes resultados contribuírem para a avaliação do perigo dos NMs testados, 
os verdadeiros efeitos da sua exposição para a saúde humana ainda não são claros e é difícil 
apresentar uma conclusão inequívoca, dada a inconsistência dos resultados apresentados na literatura. 
Assim, a aplicação de alguns nanomateriais em produtos de consumo deve ser avaliada 
cuidadosamente até que estejam estabelecidas conclusões relativamente à sua segurança.  
 
Palavras-chave: nanomateriais, citotoxicidade, genotoxicidade, dispersão de nanomateriais, células 
A549. 
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1. INTRODCUTION 
 
Nanotechnology involves the manipulation and application of engineered particles or systems 
that have at least one dimension under 100 nanometers (nm) in length (Stone et al. 2009; Arora et al. 
2012; Ferreira et al. 2013). 
Nano-object is defined as a material with one, two, or three external dimensions in the size 
range from approximately 1–100 nm. There are subcategories of nano-object such as nanoparticle (NP), 
defined as a nano-object with all three external dimensions at the nanoscale. Nano-objects are 
commonly incorporated in a larger matrix or substrate referred to as a nanomaterial (NM). The term 
manufactured nanomaterial describes nanoparticles (NPs) intentionally produced and designed with 
very specific properties or compositions (e.g., shape, size, surface properties, and chemistry) (NIOSH 
2009). In 2011, the European Commission adopted the definition of nanomaterial (NM) as “a natural, 
incidental or manufactured material containing particles, in an unbound state or as an aggregate or as 
an agglomerate and where, for 50 % or more of the particles in the number size distribution, one or more 
external dimensions is in the size range 1 - 100 nm”. 
(http://ec.europa.eu/environment/chemicals/nanotech/faq/definition_en.htm; Consulted on 22/7/2015) 
Some authors do not distinguish the term nanoparticle (NP) and nanomaterial (NM) in their 
works, using it indistinguishably and assuming the same definition. Hence, in this work these two terms 
will be assumed as being the same to facilitate the comprehension.  
 
According to several authors, unique and unusual physical, chemical, and biological properties 
can be seen at the nanosize level. While the properties of bulk materials at the molecular level are 
largely understood there are new properties of materials being discovered in the zone between molecule 
and bulk. When bulk materials are made into smaller and smaller pieces of matter their surface chemistry 
changes and chemical reactivity increases or, in other words, there are a higher number of molecules 
available to react with the environment. Also, at the nanoscale, quantum physics can direct the 
behaviour of a particle; the influence of quantum effects can change important material properties, such 
as optical, magnetic, and electrical properties (Ferreira et al. 2013; Arora et al. 2012; Elsaesser & 
Howard 2012; Azqueta & Dusinska 2015). 
These materials are increasingly being used in industry and consumer products such as fillers, 
opacifiers, catalysts, water filtration, semiconductors, microelectronics, cosmetics, or even in biomedical 
applications, leading to direct and indirect exposure of humans (Arora, Rajwade, and Paknikar 2012). 
Hence, the very same properties that lead to the technical advantages of using nanomaterials also may 
lead to unique biological effects. High reactivity potentially could be related to toxicity due to harmful 
interactions of nanomaterials with biological systems and the environment (Arora, Rajwade, and 
Paknikar 2012). Nanoparticles toxicity is extremely complex and multifactorial and depends on a 
multiplicity of physicochemical properties such as size, shape, surface properties, chemical composition, 
charge, surface structure and area, solubility and aggregation. Ultrafine or nanosize range (<100 nm) 
particles seem to be more toxic compared to larger particles of identical chemical composition (Ferreira, 
2 
 
Cemlyn-Jones, and Robalo Cordeiro 2013). Thus, concerns have been raised about their safety profiles. 
One particular area of concern is that of airborne nanomaterials and the potential harms that may result 
in the respiratory tract (Ferreira et al. 2013; Frieke Kuper et al. 2015).  
 
 
 
1.1 Nanotoxicology 
Nanotoxicology was proposed as a new branch of toxicology to address the gaps in knowledge 
about nanomaterials’ toxic effects to human health and the environment towards  the development of a 
sustainable and safe nanotechnology (Arora et al. 2012; Ferreira et al. 2013). In this sense, 
nanotoxicology encompasses the physicochemical properties, routes of exposure, biodistribution, 
molecular determinants, genotoxicity, and addresses also regulatory aspects. In addition, 
nanotoxicology is involved in proposing reliable, robust, and data-assured test protocols for 
nanomaterials in human and environmental risk assessment (Ferreira, Cemlyn-Jones, and Robalo 
Cordeiro 2013).  
Toxicological assessment of manmade NMs requires information about the route of exposure 
(inhalation, oral or dermal). The most common scenarios for human exposure to NMs are occupational, 
environmental and the consumer ones and one of the most important routes of human exposure to 
airborne NPs is inhalation, both at the workplace and from the environment (Ferreira, Cemlyn-Jones, 
and Robalo Cordeiro 2013). When inhaled, particles reach the alveolar epithelial surface where they 
can interact with alveolar macrophages and epithelial cells (Herzog et al. 2007). The deposition mainly 
takes place in the alveolar region (Arora, Rajwade, and Paknikar 2012). After translocation across the 
lung epithelium, NMs can enter the blood and lymph circulation to reach cells in the bone marrow, lymph 
nodes, spleen and heart, among other organs (Arora, Rajwade, and Paknikar 2012). 
Warheit (2008) has put a question “how meaningful are the results of nanotoxicity studies in the 
absence of adequate material characterization?” This suggests that it is extremely important to 
characterize the nanomaterials during the study in the culture medium where the cells are seeded. 
Recent research has demonstrated that NMs polydispersity and agglomeration stability can have 
profound impacts on NMs’ toxicity in in vitro tests. Harmonized methods for in vitro nanotoxicity 
assessments must therefore include NMs dispersion preparation and characterization protocols that 
ensure fairly monodispersed and stabilized NM suspensions suitable for in vitro cellular studies (Cohen 
et al. 2013). In chapter 1.4.1- Nanomaterials’ dynamic behavior and dispersion in aqueous medium- this 
subject will be discussed in more detail. 
 
 
1.1.1. Cytotoxic effects of nanomaterials 
Most of the NPs are expected to be biopersistent in biological settings, such as the respiratory 
system (Ferreira et al. 2013; Herzog et al. 2007).  Besides, size, shape, presence of transition metals, 
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aggregation and the capacity to generate reactive oxygen species (ROS) also explain the potential for 
lung damage (Ferreira, Cemlyn-Jones, and Robalo Cordeiro 2013).  
NMs can interact with cellular and mitochondrial membranes or alter mitochondrial function, 
provoking the production of reactive oxygen species and inducing DNA oxidation. ROS include free 
radicals such as the superoxide anion (O2•−), hydroxyl radicals (.OH) and the non-radical hydrogen 
peroxide (H2O2), which are also constantly generated in cells under normal conditions, as a 
consequence of aerobic metabolism (Arora, Rajwade, and Paknikar 2012). ROS, due to their high 
chemical reactivity, can react with DNA, proteins, carbohydrates and lipids causing cell death either by 
apoptosis or necrosis or even inflammatory responses.  
 
 
1.1.2. Genotoxic effects of nanomaterials 
The genotoxicity associated to nanomaterials may be classified as primary or secondary 
genotoxicity. The former may result from a direct pathway when NPs reach the nucleus (via nuclear 
pores or during mitosis) and directly interact with DNA organized in chromatin or chromosomes 
(depending on the phase of cell cycle). During interphase NPs can interact or bind to the DNA molecule 
and can influence its replication or transcription into RNA. During mitosis NPs can interact with 
chromosomes, causing clastogenic or aneugenic effects. NPs might induce breaks in chromosomes or 
disturb the process of mitosis, either mechanically or by chemical binding to DNA bases. Indirect 
genotoxicity may happen through interaction with nuclear proteins (involved in replication, transcription, 
repair), or with the mitotic spindle or its components, leading to aneuploidy (aneugenic effect); other 
indirect effects include the disturbance of cell cycle checkpoint functions, induction of ROS arising from 
NP surface or inhibition of the cellular antioxidant defense (Stone et al. 2009; Magdolenova et al. 2014). 
On the other hand, secondary genotoxicity implies a pathway of genetic damage resulting from oxidative 
DNA attack by ROS that are generated from phagocytes (neutrophils, macrophages) activation during 
particle-elicited inflammation. NMs can also induce genotoxic effects by depleting the antioxidant 
defenses or altering the DNA repair systems. All these events may result in pre-mutagenic lesions that 
can lead to mutations and, possibly, to cancer and other diseases on the long-term (Azqueta & Dusinska 
2015; Magdolenova et al. 2014).  
Many methods have been developed to assess the genotoxicity caused by nanomaterials that 
will be discussed in the next chapter 1.4.4. 
 
 
 
1.2 The NANoREG Project 
The NANoREG project is the first FP7 (7th Framework Programme for Research and 
Technological Development) project to deliver the answers needed by regulators and legislators on 
Environmental Health Science (EHS) by linking them to a scientific evaluation of data and test methods.  
The aims of NANoREG project are: (i) provide answers and solutions from existing data, 
complemented with new knowledge, (ii) provide a tool box of relevant instruments for risk assessment, 
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characterization, toxicity testing and exposure measurements of manufactured nanomaterials, (iii) 
develop, for the long term, new testing strategies adapted to innovation requirements, (iv) establish a 
close collaboration among authorities, industry and science leading to efficient and practically applicable 
risk management approaches for manufactured NMs and products containing manufactured NMs. 
(http://www.nanoreg.eu/; consulted on 6th August 2016) 
The NANoREG project has about 70 partner institutes (Fadeel et al. 2015) and in Portugal, the 
NANoREG project is represented by Institute of Welding and Quality (ISQ), which is coordinating a 
platform called PToNANO, formed by four entities whose competencies are complementary in the field 
of nanotechnology. The other 3 entities are the National Institute of Health Doutor Ricardo Jorge, I.P. 
(INSA), the Portuguese Institute for Quality, I.P. (IPQ) and the Directorate-General of Health 
(DGS)(http://www.nanoreg.eu/; consulted on 6th August 2016) 
The NANoREG project uses benchmark nanomaterials from the Joint Research Center (JRC) 
repository (Fadeel et al. 2015).  
 
 
1.3 Metallic Nanomaterials 
1.3.1 Cerium Dioxide (CeO2) 
Cerium (Ce) is the most abundant rare-earth metals found in the earth’s crust which has been 
recently introduced for specialty applications (Kumari et al. 2014; Dahle et al. 2015) and is found in 
nature along with other lanthanide elements in the minerals alanite, bastanite, monazite, cerite and 
samarskite. However, CeO2 has fluorite as the most stable crystalline phase (Prospect Global 
Nanomaterials Safety 2010).  
 
 
 
Figure 1.1- TEM image of NM-212, showing irregular and non-homogeneous primary particle 
size variation (C. Singh et al. 2014). 
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Larger particles of this material (bulk material) may induce optical lens grinding, itching, 
sensitivity to heat, skin lesions, pulmonary fibrosis (Rim, Koo, and Park 2013) and pneumoconiosis 
(Prospect Global Nanomaterials Safety 2010).  
Owing to their large surface area to volume ratio, CeO2 NPs (nanoceria, Figure 1.1) have unique 
electronic structure and the reduction in the particle size results in the formation of surface oxygen 
vacancies, which endows it with the ability to exist in either Ce3+ or Ce4+ state on the particle surface 
(Kumari et al. 2014).  
Nanoceria play several catalytic roles such as catalysts in the petroleum refining industry, as 
additives to promote combustion of diesel fuels, in catalytic converters in cars enabling them to run at 
high temperatures, as sub-catalysts for automotive exhaust cleaning and as electrolytes in solid oxide 
fuel cells (Kumari et al. 2014; Dahle et al. 2015; Rim et al. 2013; Leung et al. 2015; Landsiedel et al. 
2014; Keller et al. 2014). The CeO2 NPs can also be employed as polishing agents, UV-scattering 
agents in non-irritating lipsticks, outdoor paint, wood care products, gas sensors, and in metallurgic and 
glass and ceramic applications (Kumari et al. 2014; Manier et al. 2013; Frieke Kuper et al. 2015; Van 
Koetsem et al. 2015). Recently, CeO2 has been the subject of many studies regarding its use as potential 
material for ultraviolet (UV) filtration. In the UV radiation range reaching the Earth’s atmosphere, the 
ultraviolet type B sub-range (UVB, 290–320 nm) is already well filtered by nanostructured TiO2 in 
sunscreen cosmetic products (Truffault et al. 2010; Boutard et al. 2013).  
Nanoceria, considered one of the most interesting nanomaterials for their catalytic properties, 
also are promising for therapeutic applications. Due to the presence of oxygen vacancy on its surface 
and the autoregenerative cycle of its two oxidation states, Ce3+ and Ce4+, nanoceria can be used as an 
antioxidant agent. Because many human disorders are associated with oxidative stress, CeO2 NPs 
might be used in future for the treatment of those pathologies (Rim et al. 2013; Leung et al. 2015). It 
was even proposed that nanoceria protect against hepatic oxidative damage and the progress of 
cardiomyopathy, which was attributed to their antioxidant properties (Leung et al. 2015).  Consequently, 
they are considered to be of interest for biomedical applications for their antioxidant activity.   
Some studies have been conducted with the aim to investigate these assumptions and try to 
explain why and when are these effects observed. The best explained and currently accepted 
mechanism to justify these results is the intrinsic material properties, including the mixed valence state 
of CeO2 (Ce3+ and Ce4+), allowing this material to act as a free radical scavenger (Xia et al. 2009; 
Schubert et al. 2006). Moreover, the electron defects in nano-ceria are relatively resistant to the radical 
damage, thereby allowing an autoregenerative reaction cycle (Ce3+ → Ce4+ → Ce3+) that perpetuates 
the scavenging activity (Xia et al. 2009; Das et al. 2007). Hence, it was proposed that Ce3+ produced by 
the reduction of Ce4+ interacts with oxygen molecules (O2), and generates superoxide anions. The two 
superoxide anion molecules interact and are converted to hydrogen peroxide, and then the hydrogen 
peroxide converts to hydroxyl radicals. The presence of the mixed valence states of Ce3+ and Ce4+ on 
the surface of the nanoceria acts as an anti-oxidant that allows the nanoparticles to scavenge free 
radicals from the culture system. Ce3+ reacts with hydroxyl radicals (Park et al. 2008). A review reported 
that nano ceria could also have superoxide dismutase,  catalase and  peroxidase mimetic activity 
besides the hydroxyl radical scavenging properties, already referred (Xu and Qu 2014).  
6 
 
There are other publications that report this radical scavenging of CeO2 nanoparticles as the 
mechanism of neuro-protection in the spinal cord neurons of adult rats (Das et al. 2007) and the cerium 
NPs are neuro-protective in cultured HT22 cells, which are derived from the rodent nervous system 
(Schubert et al. 2006). Park et al. (2008)  tried to justify their results in Beas-2B cells reporting that the 
particle which they prepared do not have the same arrangement and do not have the same Ce3+ ionic 
state enough to scavenge the oxygen radicals, when they addressed the antioxidant mechanism of 
cerium oxide nanoparticles. This may be the difference between the neuroprotection in adult rat spinal 
cord (referred study) and the cytotoxicity in Beas-2B cells obtained by the authors (Park et al. 2008). In 
fact there are already available some studies that report the effect of the size in the relative amount of 
cerium ions Ce3+ and Ce4+ saying that, in general, the fraction of Ce3+ ions in the particles increases 
with decreasing particle size (Xu & Qu 2014; Schubert et al. 2006). Besides the in vitro studies presented 
above, it was also related that nanoceria remains deposited in tissues and may decrease ROS in mice, 
thereby suggesting again that cerium oxide nanoparticles may be a useful anti-oxidant treatment for 
oxidative stress (Hirst et al. 2009).  
However, biomedical and toxicity studies of nanoceria, which focused predominantly on their 
redox properties, have resulted in contradictory conclusions about their effects. While some authors 
documented that nanoceria may act as antioxidants and protect cells against oxidative damage and 
ionizing radiation, and improve cardiac function, others reports found them to be cytotoxic and to induce 
oxidative stress (Lee et al. 2012; Rim et al. 2013). 
Because of the rapidly growing demand of cerium in nanotechnology, the release of this NM is 
expected to increase in the environment. The majority of Ce NPs residues are likely to be discharged in 
wastewater treatment plants and/or be partially accumulated in the sludge that is later used for soil 
amendments. Thus, industrial wastewaters serve as a significant environmental source of CeO2 NPs 
(Dahle, Livi, and Arai 2015). For such reason, the Organization for Economic Co-operation and 
Development (OECD) in the Environment Directorate added CeO2 NPs in the list of 14 NMs for testing 
and identified it as commercially relevant to the global economic impact of nanotechnology. It has been 
suggested that the most common route of CeO2 exposure is likely to be through inhalation and/or 
ingestion (Kumari et al. 2014; Manier et al. 2013; Verstraelen et al. 2014; Franchi et al. 2015; Bour et 
al. 2015; Keller et al. 2014). 
There is ongoing exposure of a large population set to new diesel emissions generated from 
fuel additives containing CeO2 nanoparticles that may be inhaled by humans. Besides alveolar 
macrophages, bronchial and alveolar epithelial cells are among the principal cells that get into contact 
with airborne NPs that penetrate into the lung. As a consequence of this interaction, these cells are 
capable of producing pro-inflammatory mediators that have the ability to elicit both a local and systemic 
inflammatory response (Rim et al. 2013; Verstraelen et al. 2014; Kumari et al. 2014). 
Concerning toxicity assessment, it was proposed that CeO2 nanoparticles may cause oxidative 
stress and/or production of reactive oxygen species (ROS), cell membrane damage, or a rise in the 
intracellular ROS caused by the direct contact between the cells and the nanoparticles (Leung et al. 
2015). The ROS production has been proposed as the cause of toxicity for different nano metal oxides, 
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such as TiO2, ZnO, and CeO2. It has been proposed that the nano metal oxide induced ROS can cause 
lipid peroxidation, cell membrane damage (Leung et al. 2015) and, possibly genotoxicity.  
 
As to cell uptake of this NM, a study demonstrated the internalization of 8-20 nm CeO2 NPs in 
A549 cell line (Mittal and Pandey 2014). A study in endothelial cells have reported that nanoceria can 
be uptaken into cells and widely distributed in multiple compartments of the cells. The results indicated 
that nanoceria can be also uptaken into cells through mediated endocytosis. Nanoceria were distributed 
throughout the cytoplasma but not into nucleus (S. Chen et al. 2013). Also in monocytes TEM revealed 
that CeO2 NPs were internalized and found either in vesicles or free in the cytoplasm (Hussain et al. 
2012).  Moreover, an in vivo study in CD1 mice also showed the internalization, accumulation and 
translocation of CeO2 NMs behind the pulmonary organs (Aalapati et al. 2014). The presence and 
retention of cerium oxide nanoparticles in lung tissue, and alveolar macrophages was also revealed (Ma 
et al. 2012).  
 
 
1.3.2 Titanium Dioxide (TiO2) 
Titanium dioxide (TiO2) is considered as an inert and safe material and has been used in many 
applications for decades. Furthermore, TiO2 is accepted as a food and pharmaceutical additive. In the 
United States it is included in the Food and Drug Administration (FDA) Inactive Ingredients Guide for 
dental paste, oral capsules, suspensions, tablets, dermal preparations and in non-parenteral medicines. 
However, with the nanotechnologies’ development, TiO2 NPs (Figures 1.2, 1.3 and 1.4), displaying novel 
and useful properties are being increasingly manufactured and used. Therefore, increased human and 
environmental exposure can be expected, which has put TiO2 NPs under toxicological scrutiny (Skocaj 
et al. 2011).  
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Figure 1. 2- TEM-micrograph of NM-100 showing the range in agglomerate and aggregate sizes 
in the material (Rasmussen et al. 2014). 
 
 
 
 
 
Figure 1. 4- Micrograph of NM-101, illustrating that the aggregates/agglomerates have a very 
irregular surface (Rasmussen et al. 2014). 
Among NMs, TiO2 is one of the most manufactured NM worldwide. TiO2 NPs are widely used in 
industry for plastics, papers, inks, medicines, food products, cosmetics, toothpastes and skin care 
products, among others. It also has photocatalytic properties that have resulted in the use of TiO2 NPs 
as an environment and wastewater disinfectant. Furthermore, TiO2 NPs have been used as a 
photosensitizer for the photodynamic therapy of human colon carcinoma cells (Singh et al. 2009; 
Medina-Reyes et al. 2015; Jugan et al. 2012; Huerta-García et al. 2014; Chen et al. 2014). In fact, at 
present, titanium dioxide are the most common ingredient in mineral sunscreens. Because of their high 
photostability and low photoallergic potential, they are often preferred over organic filters (Boutard et al. 
2013). 
These particles are in the breathable size range and several toxic effects have been described 
after their inhalation. Tissue deposition of NPs and their toxicity are closely related to the route of 
exposure and, in this sense, keratinocytes have been studied as the primary target of dermal exposure, 
lung tissue as the target for inhalation, and intestines, kidney, and liver for oral exposure. The lung is 
Figure 1. 3- Representative TEM micrograph of well-dispersed sample of NM-101 taken for 
quantitative TEM-analysis; scale bar is 500nm (Rasmussen et al. 2014). 
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the best characterized organ regarding the toxic effects induced by TiO2 NPs (Huerta-García et al. 
2014).  
Although these NPs are considered safe for use in sunscreens by the US FDA, there is a 
considerable concern with this ruling as sunlight because illuminated TiO2 may induce DNA damage 
both in vitro and in vivo. When exposed to UV light, TiO2 catalyses the generation of reactive oxygen 
species, such as superoxide anions, hydrogen peroxide, free hydroxyl radicals, and singlet oxygen in 
aqueous media (N. Singh et al. 2009).  
In vivo studies have provided evidence that TiO2 NPs can cause inflammation, fibrosis, 
pulmonary damage and even DNA damage. Toxicity assessment has been performed in rats tissues 
and revealed that this NM caused lungs injury and inflammation due the increasing number of red blood 
cells. The results of lung tissue lipid oxidation accessed by malondialdehyde (MDA) content confirmed 
that the damage of lung tissue was indeed related with the generation and accumulation of ROS (Tang 
et al. 2013). These authors explained that the toxicity and ROS formation begun in mitochondria that 
carried out aerobic respiration. Most of oxygen was combined with electrons which came from electronic 
transmission chain at inner mitochondrial plasmalemma and formed H2O after a series of oxidation–
reduction reactions. However, a small amount of oxygen formed superoxide which was the major source 
of ROS in cells. The cumulative ROS attacked the mitochondria and restrained the functional activity of 
mitochondria and, as a result, the cell was approaching to apoptosis (Tang et al. 2013; Huerta-García 
et al. 2014). A simple schematic representation of this mechanism is represented in figure 1.5.  
 
 
Figure 1. 5- Schematic representaion of the proposed mechanism for ROS formation and 
effects in the cell (from Tang et al. 2013) 
However, these animal studies are limited and in vitro studies are required for more mechanistic 
insights.  
 
Given that oxidative stress and inflammation are associated with indirect and secondary 
genotoxicity via the damaging activity of ROS, it seems likely that exposure to TiO2 NPs may indirectly 
result in DNA lesions and several studies have demonstrated this effect (Singh et al. 2009; Jugan et al. 
2012).  
Based on the data available, the International Agency for Research of Cancer (IARC) has 
classified the TiO2 NPs as a possible carcinogen to humans, and the National Institute for Occupational 
Safety and Health (NIOSH) has determined that TiO2 is a potential occupational carcinogen by inhalation 
(Medina-Reyes et al. 2015).  
In an exposure scenario, after absorption, TiO2 NPs can be translocated to all regions of the 
respiratory tract (Huerta-García et al. 2014). In V79 (Chinese hamster lung cells) the viability was 
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significantly decreased at 24 and 48 hours, when exposed to 5 to 100 µg/mL of TiO2 NPs (Chen et al. 
2014). 
Their small size facilitates uptake into cells and transcytosis across epithelial and endothelial 
cells into the blood and lymph circulation to reach potentially sensitive target sites, such as bone marrow, 
lymph nodes, spleen, and heart. There is increasing evidence that NPs can cross the blood–brain barrier 
independent of the route of exposure (Huerta-García et al. 2014). Because TiO2 NPs can translocate to 
different organs and into the CNS (Huerta-García et al. 2014), diverse studies have been made in cell 
lines other than those representative of the respiratoty tract. A study evaluated their possible toxic effect 
on glial cells (U373 cells) and reported that TiO2 NPs induce a strong oxidative stress in U373 cells, 
mediating changes in the cellular redox state, which was correlated with increase in antioxidant enzyme 
expression and lipoperoxidation (Huerta-García et al. 2014). In human fetal lung fibroblasts (HFL1) the 
results from MTT indicated that TiO2 NMs (21 nm 80% A, 20% R) induced a decrease in cell viability at 
low doses (0.25 to 1.50 mg/mL) (Z. Qiang et al. 2013). A study in normal untransformed human 
fibroblasts (GM07492) with TiO2 NPs in a range concentrations from 0 to 100 µg/mL also showed 
significant decrease in cell viability at 100 µg/mL (Franchi et al. 2015). The MTT assay in human amnion 
epithelial (WISH cells) cells revealed a concentration-dependent decline in the cell survival after 
exposure to TiO2 NPs (30,6 nm) for 24 hours at  0.625 to 10 µg/mL (Saquib et al. 2012). Significant 
cytotoxicity, intracellular ROS generation, and to some extent G2/M cell cycle arrest were induced at 
the above specified treatment doses, and attributed to TiO2 NPs mediated oxidative stress in the WISH 
cells (Saquib et al. 2012).  
As to the internalization studies of TiO2 NPs, different techniques have been employed. The 
flow cytometry analyses revealed that these NPs were not only internalized but also adhered to the 
surface of A549 cells (Moschini et al. 2013). Another study also verified the accumulation of the smallest 
NPs in the cytoplasm and in the nucleus of A549 cells, once again proving the capacity of A549 cells to 
internalize NMs (Jugan et al. 2012). Other techniques as Raman imaging (Ahlinder et al. 2013) TEM 
(Aueviriyavit & Phummiratch 2012; Franchi et al. 2015)  Static light scattering, in-vitro Raman 
microspectroscopy (Andersson et al. 2011) have shown the uptake to the nucleus (Ahlinder et al. 2013) 
and in the cytoplasm relating that the agglomerates can be taken up by the cells and largely accumulated 
in the endosomes, probably via endocytosis (Aueviriyavit & Phummiratch 2012; Franchi et al. 2015; 
Tang et al. 2013).  All these studies were conducted in A549 cells. The internalization of TiO2 NPs (30-
70 nm) was also verified in the human liver cells (HepG2) through electron microscopy and flow 
cytometry (Vallabani et al. 2014). 
Because NPs can be internalized by cells and some of these NPs also can cross the nuclear 
membrane, the direct interactions between NPs and the nucleus may be the main cause of genotoxicity, 
leading to DNA or chromosome breaks. When NPs do not reach the nucleus, the genetic material is 
exposed to the NMs during cellular division (Elsaesser and Howard 2012). In contrast to these data 
suggesting a significant genotoxic potential of TiO2 NPs, other authors show that acute exposure to 
TiO2 NPs do not cause DNA damage (Xie et al. 2010; Bhattacharya et al. 2009; Landsiedel et al. 2010). 
This discrepancy may be explained by differences in physicochemical properties of TiO2 NPs 
and their suspensions, e.g., different NP diameter, crystalline phase, and/or specific surface area, or 
11 
 
different agglomeration status. It may also be explained by the use of different cell lines that may differ 
in terms of susceptibility to TiO2 toxic potential (Jugan et al. 2012; Chen et al. 2014). 
1.3.3 Barium Sulphate (BaSO4) 
Chronic exposure to high levels of micron-scale BaSO4 may induce pneumoconiosis (baritosis) 
in miners (Konduru et al. 2014). Baritosis is one of the benign pneumoconioses in which inhaled 
particulate matter lies in the lungs for years without producing symptoms, abnormal physical signs, 
incapacity for work, interference with lung function, or liability to develop pulmonary or bronchial 
infections or other thoracic disease (Doig 1976).   
Barium sulfate nanomaterials already have some applications in different industries and are 
considered a member of the poorly soluble particles (PSP) or poorly soluble low toxicity (PSLT) particle 
groups, as are cerium dioxide (CeO2) and titanium dioxide (TiO2); this nanomaterial is used as fillers in 
coatings (e.g. in motor vehicles) due to their mechanical, optical and chemical properties (Konduru et 
al. 2014) and it is also introduced into bone cements to increase radio-opacity so that they may be 
visualized through X-ray imaging, (Gillani et al. 2010). It is being used as a filling material in polymer 
compositions to increase scratch resistance while conserving transparency (Keller 2015), is a common 
agent added to catheters or endotracheal tubes which make such medical tubing radiopaque. In 
addition, BaSO4 polymeric formulations have been shown to exhibit some antimicrobial activity 
(Aninwene et al. 2013).  
Relatively to toxicity studies, there are only a few publications related to in vivo experiments. A 
study revealed that pulmonary exposure to instilled BaSO4 NPs caused dose-dependent lung injury and 
inflammation. Four-week and 13-week inhalation exposures to a high concentration (50 mg/m3) of 
BaSO4 NPs elicited minimal pulmonary response and no systemic effects. Instilled and inhaled BaSO4 
NPs were cleared quickly yet resulted in higher tissue retention, exhibited lower toxicity and 
biopersistence in the lungs compared to other poorly soluble NPs such as CeO2 and TiO2 (Konduru et 
al. 2014). 
To our knowledge, there are no available studies for in vitro assessment of BaSO4 nanomaterials 
through inhalation exposure. Thus, one of the objectives of this work is to assess the cytotoxicity and 
genotoxicity of this nanomaterial. 
 
 
 
1.4 Strategies and challenges in the in vitro characterization of 
nanomaterials’ toxicity 
 
1.4.1 Nanomaterials’ dynamic behavior and dispersion in 
aqueous medium 
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NPs have the tendency to both aggregate and agglomerate. An agglomerate is a “collection of 
loosely bound particles or aggregates or mixtures of the two where the resulting external surface area 
is similar to the sum of the surface areas of the individual components,” while an aggregate is defined 
as a “particle comprising strongly bonded or fused particles where the resulting external surface area 
may be significantly smaller than the sum of the calculated surface areas of the individual components” 
(Sauer et al. 2015). 
Many attempts have been made to generate stable suspensions or dispersions in case of 
insoluble NMs. However, it is often the case that the particles settle due to agglomeration and gravity 
over time in culture. It is probably therefore more appropriate to also express dose in terms of mass per 
unit surface area of the culture dish (µg/cm2) (Stone, Johnston, and Schins 2009). The effective dosage 
is influenced by the sedimentation and diffusion properties that different NMs exhibit under the given 
cell culture conditions, which largely depend upon the effective densities and diameters of the 
suspended NM agglomerates (Sauer et al. 2015).  
In culture medium or other biological fluids, NMs interact with proteins or phospholipids thereby 
forming a characteristic ‘corona’ on their surface. NMs’ tendency to agglomerate is governed by its 
surface properties that can change spontaneously due to protein adsorption. Consequently, corona 
formation directly affects the type and extent of NM agglomeration, and the type of NM dispersing agent 
used influences in vitro particle kinetics (Sauer et al. 2015; Cohen et al. 2013). In vitro test systems 
should be relevant for the in vivo situation they mimic. The biological proteins and lipids surrounding a 
NP determine its biological fate, since it is this corona that cells encounter and interact with. When 
nanoparticle-protein complexes pass from one biological fluid to another, the corona is assumed to 
change due to competitive adsorption of different biomolecules. Only the small fraction of NPs that can 
pass the air-blood-barrier would experience a corona shift towards the higher affinity of serum 
components, followed by a comparatively less pronounced, but still considerable agglomeration (Sauer 
et al. 2015). 
Different NM dispersants have been investigated, including natural lung surfactants, 
phospholipids, organic solvents, and serum or albumin additives (Sauer et al. 2015). A number of studies 
have now demonstrated that small concentrations of protein (usually albumin below 1% final 
concentration) improve particle dispersion and the stability of that dispersion over time, especially if 
incorporated in the medium prior to particle addition, and if combined with a short sonication (e.g. 10 
min) (Stone, Johnston, and Schins 2009). Of course, adding protein or other dispersants to the 
nanoparticles could influence their surface properties and therefore their interaction with cells and other 
biological molecules. This suggests that either the improved dispersion aids uptake of the smaller 
agglomerates and/or individual NPs or, alternatively, that the proteins adsorbed to the particle surface 
interact with cell surface receptors that facilitate uptake into the cells (Sauer et al. 2015). 
To verify the stability of the NPs suspension there are some techniques already available that 
can be easily applied. Nanoparticle Tracking Analysis (NTA) and Dynamic Light Scattering (DLS) are 
some of those techniques. In this work DLS technique was performed. The principle of the DLS stands 
on the measurement of fluctuations in laser light scattered by vibrating particles suspended in a liquid 
as function of time. The vibration is due to Brownian motion caused by collision with solvent molecules. 
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The Brownian motion varies as a function of particle size and causes variation in the intensity of 
scattered light as function of time (Keld Alstrup Jensen 2014). 
 
 
 
1.4.2 Experimental cell models 
There are a number of obvious advantages to in vitro toxicity testing of any chemical or particle, 
including the ethical desire to reduce animal testing, the speed of results, and the relatively lower cost 
compared to in vivo studies (Stone, Johnston, and Schins 2009). In vitro model systems provide a rapid 
and effective means to assess NPs for a number of toxicological endpoints. They also allow 
development of mechanistic evaluations and provide refined information on how NPs interact with 
human cells in many ways. Such studies can be used to establish concentration–effect relationships 
and the effect-specific thresholds in cells. The revelation of primary effects on target cells in the absence 
of secondary effects caused by inflammation and the identification of primary mechanisms of toxicity in 
the absence of the physiological factors are some of the interactions allowed by in vitro tests (Arora, 
Rajwade, and Paknikar 2012). These assays are suited for high-throughput screening of an ever 
increasing number of new NMs obviating the need for in vivo testing of individual materials (Stone, 
Johnston, and Schins 2009). Other advantages are reduction in variability between experiments, 
reduced requirement of test materials thereby leading to generation of limited amounts of toxic wastes. 
(Arora, Rajwade, and Paknikar 2012). A limitation is that an in vitro system is not able to fully replicate 
the complex interactions that occur between multiple cell types in vivo, both within an organ and also 
between organs (Stone, Johnston, and Schins 2009),  
There are a large number of different tumor and transformed cell-derived cell lines available. It 
is also possible to increase the complexity of these in vitro systems to include multiple cell types, e.g., 
the co-culture of epithelial cells and macrophages, with the aim to more closely mimic the in vivo situation 
(Stone, Johnston, and Schins 2009). The selection of a cell line for in vitro toxicity assessment is 
frequently driven by the toxicokinetics and toxicodynamics of the NM, namely, the main via of absorption 
and the primary site of contact or the target organ. 
Franchi et al. (2015) discussed the main differences between transformed or cancer cells and 
untransformed cell lines. They agree that the use of cancer cell lines can provide vital information, 
however they referred that their use in nanotoxicological research, especially with the aim of predictive 
toxicology for human exposure scenarios, remains questionable as multiple molecular pathways are 
potentially deregulated (including DNA repair pathways). Transformed or cancer cell lines, due to 
several mutations in cell death-related pathways, may differ quite strongly in their response to NP-
induced damage. Depending on the nature of the cancer cells and NPs, these differences may result in 
either higher sensitivity of the cancer cells or higher resistance, which may harden NP toxicity studies.  
During the evaluation of nanomaterials’ toxicity it is important to show experimentally or based 
on the literature reports whether the NPs are internalized into the cells to try to allow a better 
understanding of the mechanisms behind the nanomaterials toxicity. This knowledge allows also, in the 
case of negative results, to discard the hypothesis of inadequacy of the cell model used due a lack of 
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the interaction of the nanomaterial with the cellular components. In the present work, internalization was 
not accessed but the knowledge relies on the results from other laboratories that participated also in the 
NANoREG project.   
 
 
 
1.4.3 Cytotoxicity Assessment 
The development and validation of methods to evaluate the toxicity of NMs is regarded as one 
of the main future challenges relevant to the safety of nanotechnology (Herzog et al. 2007). In past 
years, a number of methods have been developed to study cell viability and the proliferation ability of 
cells in culture. The most convenient, modern assays have been optimized for the use of microtiterplates 
(96-well format). This miniaturization allows many samples to be analyzed rapidly and simultaneously. 
Colorimetric and luminescence based assays allow samples to be measured directly in the plate by 
using a microtiterplate reader or ELISA plate reader. Cytototoxicity assays have been developed which 
use different parameters associated with cell death and proliferation (Weyermann, Lochmann, and 
Zimmer 2005).  
 
 
 
1.4.3.1. The MTT Assay 
There are a wide variety of assays to assess cytotoxicity that are frequently based on cell 
viability measurement. One of the most common is the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay, or variations of this assay (MTS, XTT or WST-1). These assays 
principally determine cell viability through determination of mitochondrial function by measuring the 
activity of mitochondrial enzymes. The assay generates a colored product (a purple formazan), which 
can be quantified by spectrophotometric readings at a specific wavelength. The absorbance value 
generated is representative of both the cell number and the functional viability of those cells (Stepanenko 
& Dmitrenko 2015; Stone et al. 2009; Weyermann et al. 2005). Such assays can therefore detect 
proliferation as well as cytotoxicity.  
When testing NPs’ cytotoxicity, these assays end up with a suspension containing cell debris, 
the dissolved formazan, and particles themselves. It could be advantageous to centrifuge the sample at 
this stage, to transfer the supernatant to a fresh 96-well plate, and therefore to read the absorbance of 
the supernatant devoid of particles and cell debris. This reduces possible background interference due 
to the presence of particles. In fact, there are a number of additional control experiments that should be 
conducted before embarking upon a full MTT assay. First, a number of particles may generate an 
absorbance at the same wavelength as that used to quantify the colored product, leading to an 
overestimation of the cell viability (Stone et al. 2009; Stepanenko & Dmitrenko 2015). 
It would also be useful to include a positive control that is linked to the hypothesis being tested 
and a negative control particle to benchmark against the particles under investigation. A positive control 
could include alpha quartz, or a relatively toxic nanoparticle such as copper oxide. A negative control 
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could include a larger version of the test particle under investigation, or perhaps a polystyrene 
nanoparticle (negatively charged) (Stepanenko and Dmitrenko 2015). 
In the final stages of the MTT assay, solubilization of the formazan product is required using a 
solvent such as dimethylsulfoxide (DMSO) or isopropanol (Stone et al. 2009; Stepanenko & Dmitrenko 
2015). 
In order to increase the reliability of cytotoxicity assessment the combination of at least two 
different cytotoxicity assays should be employed, taking into consideration that they should measure 
different endpoints and therefore generate complementary results (Stone, Johnston, and Schins 2009).  
 
 
 
1.4.3.2. The clonogenic assay 
The clonogenic assay is used as an alternative method which avoids the use of any colorimetric 
or fluorescent indicator dye, thus eliminating the risk of interactions and allowing the assessment of true 
cytotoxicity. The clonogenic assay, also called colony formation efficiency (CFE) assay, is an in vitro cell 
survival based assay measuring the ability of a single cell to form a colony (Herzog et al. 2007). This is 
usually done by simple dilution after generating a single cell suspension and counting the colonies that 
arise from single cells. For effective and correct counting, a lower threshold, such as five or six doublings 
(32 or 64 cells/colony), is quantitated, taking into account the doubling time. For instance, the effect of 
a concentration of a drug on cell survival may be measured with this assay (Longo-Sorbello et al. 2006). 
Therefore, plating density must not be too high or colonies will coalesce and counting of single colonies 
will become impossible (Buch et al. 2012). 
 
 
 
1.4.4 Genotoxicity Assessment 
1.4.4.1. The cytokinesis-blocked micronucleus (CBMN) 
assay  
Based on the micronucleus (MN) test data on nanomaterials, it was proposed that the in vitro 
MN test is quite appropriate to screen NPs for potential genotoxicity (Arora, Rajwade, and Paknikar 
2012). 
In the cytokinesis-block micronucleus (CBMN) assay, cells that have completed one nuclear 
division are blocked from performing cytokinesis using cytochalasin-B (Cyt-B) and are consequently 
readily identified by their binucleated appearance. Cyt-B is an inhibitor of actin polymerisation required 
for the formation of the microfilament ring that constricts the cytoplasm between the daughter nuclei 
during cytokinesis. The appropriate concentration of Cyt-B is usually between 3 and 6 µg/mL (Fenech 
2000; OECD 2009). It is important to take into account that Cyt-B may take up to 6 h before it starts to 
exert its cytokinesis-blocking action (Michael Fenech 2000) and that it also inhibits endocytosis, an 
important mechanism of uptake of NMs into the cell (Azqueta and Dusinska 2015).  
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When using established or primary cell lines from dividing cell populations it is usual to add Cyt-
B shortly after exposure to genotoxin to capture all cells undergoing their first nuclear division as 
binucleated cells — this usually requires an incubation period of about 24 to 48h (1.5 to 2 cycles), 
depending on the cell cycle duration, before harvesting the cells (Michael Fenech 2000). Micronuclei 
should only be scored in binucleated cells, i.e., cells that divided in the presence or immediately after 
exposure to the agent under study  (Fenech 2000; OECD 2009). 
MN are expressed in dividing cells and contain either chromosome breaks lacking centromeres 
(acentric fragments) or whole chromosomes that are unable to travel to the spindle poles during mitosis 
(Figure 1.6). At telophase, a nuclear envelope forms around the lagging chromosomes and fragments, 
which then uncoil and gradually assume the morphology of an interphase nucleus with the exception 
that they are smaller than the main nuclei in the cell, hence the term “micronucleus” (Fenech 2000; 
Fenech et al. 2011; Kotova et al. 2015; Bonassi et al. 2011; Terradas et al. 2010).  
 
As micronuclei may arise from lagging chromosomes, there is the potential to detect aneuploidy-
inducing agents that are difficult to study in conventional chromosomal aberration tests. However, the 
CBMN assay does not allow for the differentiation of chemicals inducing polyploidy from those inducing 
clastogenicity without special techniques such as fluorescence in situ hybridization (FISH) (OECD 
2010). With probes targeted to the centromere region, it is possible to determine if a specific 
micronucleus contains  an acentric chromosome fragment (i.e. resulting from a clastogenic event), or if 
it holds an entire chromosome (i.e. aneugenic effect) (Stone et al. 2009; Fenech et al. 2011; Terradas 
et al. 2010).  
Micronuclei (MN), nucleoplasmic bridges (NPB) and nuclear buds (NBUD) are nuclear 
anomalies commonly seen in cancer and they represent a common phenotype of chromosomally 
unstable cells. Chromosomal instability leads to altered gene dosage and the potential for a cell to 
rapidly evolve and mutate, due to its genetic plasticity, into diverse abnormal genotypes that can escape 
the homeostatic control mechanisms and thus become immortalized and evade the immune system 
(Fenech et al. 2011; Bonassi et al. 2011).  
Occasionally nucleoplasmic bridges are visible between nuclei; they are observed in 
binucleated cells following exposure to clastogens. These are probably dicentric chromosomes in which 
the two centromeres were pulled to opposite poles of the cell during anaphase and the DNA in the 
resulting bridge is covered by nuclear membrane. The width of a nucleoplasmic bridge may vary 
considerably but usually does not exceed 1/4th of the diameter of the nuclei within the cell. The 
nucleoplasmic bridge should have the same staining characteristics of the main nuclei. Thus, 
nucleoplasmic bridges in binucleated cells provide an additional and complementary measure of 
chromosome rearrangement, which can be scored together with the micronucleus count (Fenech 2000; 
Fenech et al. 2011). 
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Figure 1. 6- A549 cells exposed to TiO2 NMs. A- Binucleated cell with one micronucleus; B- 
Binucleated cell with one micronucleus and nucleoplasmatic bridge; C- Binucleated cells (one cell 
with micronucleus) surrounded by TiO2 NMs. Images from the group lab. 
When anaphase bridges break unevenly, which they almost always do, one of the daughter 
cells receives a chromosome with additional copies of genes and the other daughter cell loses some 
genes (M. Fenech et al. 2011). NPB are usually broken during cytokinesis but they can be accumulated 
in cytokinesis-blocked cells using the cytokinesis inhibitor cytochalasin-B (M. Fenech et al. 2011). 
The NBUD are characterized by having the same morphology as a MN with the exception that 
they are connected to the nucleus by a narrow or wide stalk of nucleoplasmic material depending on the 
stage of the budding (M. Fenech et al. 2011). 
 
 
 
1.4.4.2 Comet Assay 
The comet assay or Single Cell Gel Electrophoresis (SCGE) (Tice et al. 2000; Azqueta & Collins 
2013), has become the most popular method for measuring DNA damage of various sorts (Figure 1.7). 
It is used in genotoxicity testing, to screen novel chemicals and pharmaceuticals, cosmetics, or other 
chemicals for potential carcinogenic properties; tests can be carried out in vivo (with analysis of various 
tissues from the experimental animal) or in vitro using suitable cultured cell lines (Azqueta & Collins 
2013; Collins 2014; Arora et al. 2012).  
Comet assay has demonstrate high sensitivity for detecting low levels of DNA damage, requires 
small numbers of cells per sample, is flexible, is low costs, is ease to employ, and the study could be 
completed in a short time (Tice et al. 2000).  
Tice et al. 2000 reported that the optimal version of the Comet assay for identifying agents with 
genotoxic activity was the alkaline- pH 13- version of the assay developed by Singh et al. 1988. The 
alkaline version is capable of detecting DNA single-strand breaks (SSB), alkali-labile sites (ALS), DNA-
DNA/ DNA-protein cross-linking, and SSB associated with incomplete excision repair sites (Tice et al. 
2000). At this pH, increased DNA migration is associated with increased levels of SSB, SSB associated 
with incomplete excision repair sites, and ALS. The induction of increased levels of SSB and ALS results 
in an increased ability of the DNA to migrate but, in contrast, the presence of DNA cross-linking reduces 
the ability of the DNA to migrate (Tice et al. 2000) (Azqueta and Collins 2013). Generally, DNA is 
denatured and unwound at pH values above 12 because of the disruption of hydrogen bonds between 
A B C 
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double-stranded DNA. At pH conditions of 12,6 or higher, ALS (e.g., apurinic sites) are quickly 
transformed to strand breaks. A pH 13 would be expected to maximize the expression of ALS as SSB 
(Tice et al. 2000).  
Because almost all genotoxic agents induce orders of magnitude more SSB and/or ALS than 
DSB, this version of the assay offered greatly increased sensitivity for identifying genotoxic agents (Tice 
et al. 2000).  
The enzyme-modified comet assay has been widely used, particularly in human biomonitoring, 
to determine background levels of oxidised bases, which is a more specific indicator of oxidative attack 
is the presence of oxidised purines or pyrimidines. The basic comet assay was modified to detect these, 
by introducing an incubation of the nucleoids (just after lysis- described below) with bacterial repair 
enzymes. The enzymes combine a specific glycosylase activity, removing the damaged base and 
creating an apurinic/apyrimidinic (AP) site, and an AP lyase which converts the AP site to a break. 
Formamidopyrimidine DNA glycosylase (FPG) acts on 8-oxo-7,8 dihydroguanine (8-oxoGua) (Collins 
2014; Azqueta & Collins 2013; Collins et al. 2014).  An increase in % tail DNA after incubation with the 
enzyme, compared with an incubation with buffer alone, indicates the presence of oxidised bases 
(Collins 2014; Azqueta & Collins 2013). These methods can be used to provide mechanistic information 
on the types of DNA damage induced by a test substance or, in some situations, to eliminate the 
possibility that the observed increase in DNA migration is due to cytotoxicity (Tice et al. 2000). The 
relationship between break frequency and % tail DNA is virtually linear, but at around 80% tail DNA, 
saturation is approached and the relationship departs from linearity. When estimating oxidised bases 
with the comet assay, it is usual to subtract the value of % tail DNA with buffer incubation, from the % 
tail DNA with enzyme incubation to obtain ‘net enzyme-sensitive sites’ (Collins 2014). 
Using independently coded slides and a blind slides scoring, at least 50 cells should be scored 
(Tice et al. 2000) in each mini gel. Each individual comet is scored to give a measure of DNA damage; 
it is often necessary to pool the results of 100 comets to obtain the overall damage level of a population 
of cells (Azqueta and Collins 2013). According to Tice et al. (2000) and (Azqueta and Collins 2013) the 
comets near the edges of the gel should not be scored. Also the particles or aggregates can localize at 
or near comet appearances, and affect their quantification due to their fluorescence or ability to quench 
DNA-staining agents such as ethidium bromide (Stone, Johnston, and Schins 2009). 
Concurrent positive and negative controls must be included in each experiment.  Examples of 
positive control substances to use in experiments include methyl methanesulphonate and ethyl 
methanesulphonate. Negative controls, consisting of solvent alone in the treatment medium, and treated 
in the same way as the treatment cultures, should be included (Tice et al. 2000).  
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Figure 1. 7- Different levels of DNA damage. A- Nucleoid without DNA breaks; B- Nucleoid with 
medium level of DNA breaks; C- Nucleoid with high level of DNA breaks (Araldi et al. 2015). 
 
 
 
 
  
A B C 
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2. OBJECTIVES 
 
The main objective of this work was to contribute for the hazard assessment of different metallic 
nanomaterials, through  the use of benchmark nanomaterials, standard procedures for NM preparation 
and toxicity assays, in order to reduce experimental variability. 
Specifically, this projects aimed to: 
 i) characterize the dynamic behavior of the different nanomaterials in the culture medium and 
detect interferences with the bioassays output;  
ii) characterize the potential of CeO2, TiO2 and BaSO4 to induce cytotoxic or genotoxic effects 
in a  human lung epithelial cell line (A549 cell line) in order to infer their possible hazard to the human 
respiratoty tract. 
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3. MATERIALS AND METHODS 
 
3.1 Cell Culture/ Cell line 
A549 cell line from American Type Culture Collection (ATCC® CCL-185™) delivered from 
Bundesanstalt für Arbeitsschutz und Arbeitsmedizin (BAuA, in English, Federal Institute for 
Occupational Safety and Health; Berlin) was the selected cellular model since this cells are from human 
lung carcinoma epithelia and this way it is possible to mimic environment in the lung when nanoparticles 
are inhaled. This line derives from an explant culture of lung carcinomatous tissue from a 58-year-old 
Caucasian male and is classified as level 1 in biosafety. The doubling time of this cell line is 
approximately 22 hours (Source: www.lgcstandards-atcc.org/Products/All/CCL-185.aspx?slp=1; 
consulted in 17th May 2016). 
The growth medium used for this cells was DMEM (Gibco by Life Technologies, Carlsbad 
California, USA), supplemented with 10% heat-inactivated Hyclone Fetal Bovine Serum (Thermo 
Scientific Waltham, Massachusetts, USA), 1% Pen/Strep, 1% Fungizone (Invitrogen, Carlsbad, 
California, USA) and 2.5% HEPES (Invitrogen, Carlsbad, California, USA). When cells reached about 
80% confluence, a subculture was performed: the culture medium was removed, the cells were washed 
and then incubated with 2 mL trypsin-EDTA (0.05%) for 4 minutes in at 37ºC (Invitrogen, Carlsbad, 
California, USA) (0.05%). When the cells were detached from the flask, the cells were subcultured in 
appropriate densities to perform the assays.  
 
 
 
3.2 Nanomaterial preparation and characterization of 
nanomaterial dispersion in the culture medium 
NMs produced, characterized and provided by the Joint Research Centre Repository (Institute 
for Health and Consumer Protection, European Commission, Ispra, Italy) were used for this study, 
namely cerium dioxide (NM-212), titanium dioxide (NM-101 and NM-100) and barium sulfate 
nanomaterials (NM-220). The detailed  physicochemical characteristics of each nanomaterial was 
previously reported by Rasmussen et al. (2014) and Singh et al. (2014) and are presented in Table 3.1. 
The dispersion of nanomaterial powder in aqueous medium was performed according to the 
NANOGENOTOX dispersion protocol (K.A. Jensen et al. 2011). Briefly, 15.36 mg of each nanomaterial 
was weighted in a vial to obtain a batch with a final and fixed concentration of 2.56 mg/mL. The 
nanomaterial was prewetted with ethanol (EtOH) (0,5 %; ≥ 96% purity) to handle hydrophobic materials 
followed by dispersion in 6 mL of sterile-filtered BSA-water consisting of water with BSA-(0.05%, w/v),  
using probe sonication. To carry on the sonication process, the vial containing the nanomaterial in EtOH 
and BSA water was placed in a box partially submerged into ice and sonicated at 400 W with 10% of 
amplitude for 16 minutes using a Branson Sonifier S-450D with 13 mm disruptor horn (Branson 
Ultrasonics Corporation, Danbury, USA). To proceed with the in vitro tests an working solution with a 
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concentration of 0,640 mg/mL was prepared for the lowest concentrations (3.2, 9.6 and 32 µg/mL); the 
concentrations of 96, 240 and 320 µg/mL were prepared directly from batch dispersion. 
 
Table 3. 1- Characteristics of NMs studied (Rasmussen et al. 2014; Singh et al. 2014; and 
according to manufacturer information (Fraunhofer IME, Germany)). 
 
Core 
material 
Morphology 
Crystalline 
phase 
Size 
(TEM) 
Surface 
area 
(BET) 
Content 
of core 
material 
[wt%] 
Coating 
(organic/ 
inorganic) 
Aggregation 
(TEM/SEM) 
NM-212 CeO2 Polyhedral 
Cubic 
cerionite 
<10 to 
100 nm 
27.2 
m2/g 
81.62 ------- Yes 
NM-101 TiO2 
Rounded or 
slightly 
elongated 
Anatase 5 nm 
316 
m2/g 
98.1 
Silanes, 
hexa- and 
oxydecanoic 
acids 
Yes 
NM-100 TiO2 
Rounded or 
slightly 
elongated 
Anatase 
20 to 
>100 
nm 
9 m2/g 97.7 no Yes 
NM-220 BaSO4 ------ ------- pending 38 m2/g ------- no ----- 
 
 
To verify the quality of the dispersion of the nanomaterial in the culture medium the 
hydrodynamic size-distribution was determined using Dynamic Light Scattering (DLS; Malvern Nano 
ZS, Malvern Inc., UK) according to SOP for measurement of hydrodynamic Size- Distribution and 
Dispersion Stability by Dynamic Light Scattering (DLS) (Keld Alstrup Jensen 2014). Samples were 
placed into 700 µL -polystyrene cuvettes and the most relevant parameters achieved in DLS: the 
Polydispersity Index (PdI) that indicates if a sample has a broad range of sizes or not; and the Z-Average 
size (Zav), which is an indicator of the average size of the particle, in nanometers of each suspension 
were assessed. The analysis was performed in the batch dispersion, soon after the sonication 
procedure, and in selected concentrations of the NMs diluted in cell culture medium: 3.2, 32 and 240 
µg/mL, corresponding to 1, 3 and 10 µg/cm2. Each sample was analyzed at 0, 3, 24, 48 hours following 
preparation and incubation at 37ºC as well as and after 7 days-incubation. During this time, NM samples 
were incubated at 37ºC, 5% CO2 to mimic best possible the in vitro test exposure conditions. Each 
analysis consisted in ten repeated measurements of hydrodynamic size were performed without pause. 
Results were compared to values that were obtained within the NANoREG Project and used as 
benchmark values. 
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3.3 Cytotoxicity Assays 
3.3.1 MTT assay 
For this assay, A549 cell line was seeded at a density of 0,5x104 cells per well in 96-well plates 
and incubated for 24 hours at 37oC with 5% CO2. After this incubation time, the cells were exposed to 
the nanomaterials NM-212, NM-101, NM-100 and NM- 220 in a range of concentrations from 0 to 100 
µg/cm2 and incubated again in the same conditions for another 24 hours. The positive control used was 
a detergent, namely SDS at 0.01%. After this exposure period the treatment was removed and the cells 
were washed twice with PBS. A volume of 100 µL of MTT (Life Technologies, Carlsbad, California) 
solution was added in each well at final concentration of 0,5 mg/mL, previously prepared in PBS (5 
mg/mL) and finally in culture medium to reach the desired concentration. The cell culture was incubated 
for a period from 2 to 4 hours in order to enable the viable cells to convert the MTT in the colored 
compound. After this time, the MTT solution was and DMSO solution was added in order to solubilize 
the purple precipitate produced by the cells and incubate for approximately for 20 minutes while 
agitating.  The final procedure consisted in measuring the absorbances of each well in a Multiskan 
Ascent Spectrophotometer (Thermo LabSystems, Waltham, MA) at 570 nm (reference filter: 690 nm). 
To allow the separation the nanomaterial from the colored supernatant the plate was centrifuged 96 well 
plate centrifuge in a Sigma 4-16 S and the supernatant was transferred to a new plate; the absorbances 
were measured again at same conditions. 
 
 
 
3.3.2 Clonogenic assay 
A549 cell line was plated in a density of 100 cells per well, in a 6-well plate and allowed to attach 
for 18 hours before exposure. This incubation time was shorter than the doubling time of this cells (22 
hours), in order to guarantee that the cells were attached but not divided ate the time of the treatment 
with nanomaterials. The cell culture were then exposed to the different concentrations (ranging from 0- 
100 µg/cm2) of the nanomaterials and incubated for 7 days, at 37oC, with 5% CO2. MMC was used as 
positive control at a final concentration of 0.00425 µg/mL. After 7 days of exposure to the nanomaterials, 
the cells were washed twice with PBS and fixed with absolute cold methanol (Merck; Darmstadt, 
Germany) for 10 minutes. Then, the plates were allowed to dry and the colonies was stained for 10 
minutes with 10% Giemsa (Merck; Darmstadt, Germany), prepared in Gurr’s buffer, washed twice with 
Gurr’s phosphate buffer and allowed to dry. The colonies formed were counted and the platting effiency 
(PE) calculated by comparing the number of cells plated initially with the number of colonies formed 
after the treatment period as well as the surviving fraction (SF) through the comparison between the 
number of the treated cells and the cells in the control. Equations 1 and 2 show the way that SF and PE 
were calculated (Munshi, Hobbs, and Meyn 2007). 
 
25 
 
 
 
𝑃𝑙𝑎𝑡𝑖𝑛𝑔 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (𝑃𝐸) =
number of colonies in the negative control
number of cells plated in each well
 x 100                                (equation 1) 
 
 
𝑆𝑢𝑟𝑣𝑖𝑣𝑖𝑛𝑔 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 (𝑆𝐹) =
PE of treated cells
PE of control
 x 100                                                                      (equation 2) 
 
 
 
 
 
3.4 Genotoxicity Assays 
3.4.1 Cytokinesis-blocked micronucleus assay (CBMN) 
Micronucleus assay was performed mainly as described in OECD- Organisation for Economic 
Co-operation and Development TG487 (OECD 2010). A549 cells were seeded in 6-well plates at a 
density of 2x105 cells per well, and incubated for 24 hours at 37oC with 5% CO2. The cells were exposed 
to nanomaterial NM-212, NM-100 and NM- 220 in concentrations ranging from 0 to 100 µg/cm2 and 
incubated for six hours at 37oC with 5% CO2. After this time Cytochalasin-B was add to each well (final 
concentration of 6 μg/mL), and cells were incubated again until 48h of exposure. The selection of this 
timepoint for adding Cytochalasin-B  intended to avoid interference of this chemical with the NMs uptake, 
as proposed by (Magdolenova et al. 2013). The positive control was Mitomycin C (MMC) (Sigma-Aldrich 
St. Louis, Missouri, EUA) which was prepared in PBS and in culture medium in a final concentration 0.1 
µg/mL. When 48 hours were reached the cells were washed with PBS twice and trypsin EDTA was 
added to detached the cultures from the wells. The suspension was then centrifuged for 5 minutes at 
1200 rpm, the supernatant was discarded and the cell pellet was ressuspended in culture medium. The 
next step was to submit the cells to a hypotonic shock with a solution of 73.5% sterile injectable bidistilled 
water, 24.5% of culture medium and 2% of inactivated FBS, added drop by drop while vortexing. The 
cells were centrifuged for 5 minutes at 1200 rpm again, the supernatant was discarded and the cells 
were ressuspended in the remained drop. Two drops of cell suspension were placed on microscope 
slides. For each treatment, two/three slides were prepared. The slides were dried at room temperature 
from 4 to 24 hours and then the cells were fixed in cold fixing solution- 3:1 methanol:acetic acid for 20. 
After a few hours or more the slides were ready to be stained with Giemsa. First of all the slides were 
immersed in Gurr’s phosphate buffer (Gibco by Life Technologies, Germany) for 10 minutes, then in a 
solution with 4% Giemsa (Merck, Darmstadt, Germany), diluted in a Gurr’s phosphate buffer for 15 
minutes and finally washed twice in the same buffer for 5 minutes. Finally the slides were allowed to dry 
and mounted with Entellan (Merck Darmstadt, Germany) and cover slips (24x60). The slides were coded 
to be analyzed in an optical microscope (Axioskop 2 Plus, Zeiss) and micronuclei were scored in, at 
least, 2000 binucleated cells from two independent cultures.  
The criteria for scoring was that the diameter of micronucleus may vary between 1/16th and 1/3rd 
of the diameter of the main nucleus (Michael Fenech 2000).  
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Also,the proportion of mono- (MC), bi- (BC) or multinucleate cells (MTC) was determined in a 
total of 1000 cells and the replication indexes- Cytokinesis-blocked proliferation index (CBPI) and 
replication index (RI) were calculated through the following equations (Tavares et al. 2014): 
 
 
CBPI =
nº mononucleated cells+2 x nº binucleated cells+3 x nº multinucleated cells
Total nº of viable cells
      (equation 3) 
 
 
 
RI =
(
nº binucleated cells+2 x nº multinicleated cells
Total number of cells
)treated cultures
(
𝑛º 𝑏𝑖𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠+2𝑥 𝑛º 𝑚𝑢𝑙𝑡𝑖𝑛𝑢𝑐𝑙𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
Total number of cells
) control culture
                             (equation 4) 
 
 
 
 
3.4.2 Comet Assay 
A549 cell line was plated at the density of 0.5x105 cells per well in a 24 well plate 
and incubated for 24 hours at 37oC with 5% CO2. The culture were exposed for 24 hours to 0-100 
µg/cm2 of NM-212, NM-101, NM-100, NM-220. Ethyl methansulfonate (EMS) (Sigma-Aldrich St. Louis, 
Missouri, EUA), the positive control was diluted in PBS (Gibco by Life Technologies, Carlsbad, 
California,USA) in a final concentration of 5mM and applied 1 hour before harvesting the cells.  
At the end of exposure, the cells were washed twice with PBS and detached from the well with 
trypsin-EDTA. Cells were centrifuged at 1000 rpm, 4ºC and 80 µL  of 0,8% low melting agarose (Sigma-
Aldrich), pre-warmed to 38°C, was added to the cell pellet. Cells were then spread on microscope slides, 
previously coated with 1% normal melting point agarose (GE Healthcare, Little Chalfont, UK), covered 
with a cover slip (20x20), and chilled on a cold surface to solidify and form a thin gel (Collins 2014). Four 
mini-gels were prepared in each slide, two slides per treatment condition. 
The slides were immersed into lysis buffer, a solution consisting of high salts’ concentration and 
detergents (Na2EDTA.H2O 100 mM, NaCl 2.5 M,Tris-HCl 10 mM, 10% DMSO and 1% Triton-X100, pH 
10. 
The lysis solution allows the removal of the cellular membranes, allowing soluble cell and 
nuclear components to diffuse away, and detach histones from the DNA. The residual structures, 
containing highly condensed DNA, still resemble nuclei but are now known as nucleoids (Collins 2014).  
Slides were incubated in lysis buffer 1-24h at 4°C and then were washed twice for 10 min in F buffer 
(HEPES 40 mM, BSA 0.2 mg/mL, KCl 100 mM, acid EDTA 0.5 mM, pH 8).  
Then, FPG enzyme (kindly provided by Dr. A. R. Collins, University of Oslo, Norway) diluted in 
F buffer, or F buffer alone, was added to each mini-gel and covered with a cover slip (24x60), and the 
slides were placed in a humidified atmosphere, to prevent dissecation, in an incubator (37°C) for 30 min. 
Cover slips were removed and the slides were immersed in electrophoresis 
buffer (NaOH 0.3 M, Na2EDTA.H2O 1 mM; pH=13), for 30 minutes, to allow unwinding and to produce 
single stranded DNA and to express ALS as SSB (Tice et al. 2000; Collins 2014). 
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Electrophoresis was performed for 25 minutes at 28 V and 300 mA at temperature around 5°C, 
since the use of a lower temperature is thought to provide increased reproducibility. During 
electrophoresis, DNA, being negatively charged, is attracted to the anode, but it only moves appreciably 
if it contains breaks (Tice et al. 2000). 
The DNA is supercoiled because it was wound around the histone cores of nucleosomes. 
Although the histones are no longer present, the supercoiling remains because the DNA loops are 
constrained by their matrix attachment. A strand break relaxes supercoiling, and so broken loops are 
able to extend towards the anode, and it is these loops that form the comet tail. The relative size of the 
tail (most conveniently measured as the % of total fluorescence in the tail) reflects the number of DNA 
loops and therefore the frequency of DNA breaks (Collins 2014). 
After the electrophoresis, the slides were washed for 10 min, first in cold PBS (Gibco by Life 
Technologies, Carlsbad, California,USA) and then, in a cold dH2O to pH neutralization. 
The slides were kept in a box, protected from the light, to dry at room temperature and were 
stained with 0,125 mg/mL ethidium bromide (Sigma-Aldrich St. Louis, Missouri, EUA). 
The analysis of the slides was done in a fluorescence microscope (Axioplan2 Imaging, Zeiss), 
with the assistance of specific image-analysis software (Comet Imager 2.2, from Metasystems, GmbH). 
In each slide 50 nucleoids were randomly analyzed per mini-gel, which results in 100 nucleoids per 
treatment condition, in replicate cultures. Two independent assays were performed for this genotoxicity 
test. 
 
 
 
3.5 Statistical analysis 
All data obtained were analyzed with IBM SPSS Statistics 20.  
In the cytotoxic assays, namely Clonogenic Assay and MTT the results were analyzed through 
One-Way ANOVA and Post- Hoc tests, provided the data followed a normal distribution. Otherwise, non-
parametric tests were applied, such as Kruskal-Wallis and Mann-Whitney to compare differences 
between the tested concentrations and the negative control. 
In the comet assay, it was assumed that the data follow a normal distribution and then One-Way 
ANOVA and Post-Hoc tests were applied. The differences between the results with and without FPG 
were analyzed using Student’s t-test. 
Two-sided Fisher’s exact test was applied to analyze the results of Micronucleus Assay so it 
was possible to assess the frequency of micronucleated binucleated cells between nanomaterial 
exposed cultures and control cultures. For RI and CBPI analysis non-parametric Kruskal-Wallis test was 
required. 
In addition, the existence of a dose-response relationship for the DNA in tail (%) was explored 
by regression analysis.  
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4. RESULTS 
4.1 Cerium dioxide nanomaterials 
4.1.1 Characterization of the nanomaterial dispersion in the 
culture medium  
As mentioned before, the protocol used for the dispersion was a standard procedure that was 
developed in the NANOGENOTOX project, with the aim of ensuring the stable dispersion of the 
nanomaterials and reducing agglomeration/aggregation.  
To verify the size of the NPs and the dispersion stability over time, the DLS technique was 
employed and the results are presented in Figures 4.1. to 4.4. The measurements were performed at 0 
hours (right after the sonication), 24 hours, 48 hours and in a range time between 5 and 7 days, in the 
culture medium, for concentrations of 1, 10 and 75 µg/cm2 (3.2, 32, 240 µg/mL), respectively. Each time 
was selected to match the times of exposure performed in each assay. The characterization of 
nanomaterials dispersion 3 hours after sonication was also performed in the first place, but results are 
not presented since they were not different from the initial dispersion and the 24 hours timepoint was 
more useful for the study.  
 
Note that in this work the concentrations are expressed in µg/cm2, but in some studies the 
concentrations are presented in µg/mL; that way the concentrations used here were 1, 3, 10, 30 and 
100 µg/cm2 corresponding to 3.2, 9.6, 32, 96, 240 and 320 µg/mL, respectively. It makes easier the 
comparison of the results.  
 
 
 
Figure 4. 1- Size distribution of the batch dispersion of NM- 212 (2.56 mg/mL) soon after 
sonication in 0.05%.BSA- water  
The quality of the batch dispersion is an important feature to decide whether the assay should 
be carried out or not. Only size distributions in the nanomateric scale should be accepted to pursue 
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assays. Figure 4.1 shows the distribution of sizes for nanomaterial NM-212 immediately after the 
sonication in BSA-water. In this case PdI was 0.19±0.11 and Zav was around 311.4±66.61 nm, where is 
localized the main peak. These results agree with Nanoreg benchmark data where Zav was 321.1 nm 
and PdI 0.31. 
 
 
 
    
 
Figure 4. 2- Size distribution of NM- 212 for concentration 3.2 µg/mL in cell culture medium at 0, 
24 and 48 hours after dispersion and incubation at 37ºC. 
 
 
Figure 4. 3- Size distribution of NM- 212 for concentration 32 µg/mL in cell culture medium at 0, 
24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
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Figure 4. 4- Size distribution of NM- 212 for concentration 240 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
The figures 4.2., 4.3 and 4.4 present the size-distributions of each tested concentration (3.2, 32 
and 240 µg/mL at different time points: right after the sonication, after 24 and 48 hours and 7 days. The 
PdI and Zav values are presented in table I.1 (see annexes). It is possible to see that the dispersion 
was stable in culture medium all over the time, since the peaks showed up well defined, with a fine 
dispersion. However, for concentrations 32 µg/mL after 7 days, a secondary peak appears and it was 
intensified in concentration 240 µg/mL also after 7 days. These secondary peaks may correspond to 
aggregated or agglomerated nanoparticles, since the Zav value also increases indicating an increment 
in particles size. 
 
 
 
4.1.2 Cytotoxicity Assessment 
To assess the possible cytotoxicity of each nanomaterial two assays were performed, with 
different times of exposure, namely the MTT (24h) and the clonogenic assay (7 days). Moreover, the 
CBPI and the RI obtained from the micronucleus assay give also a measure of the cells capacity to 
divide and proliferate and thereby the results of these indexes are also herein presented. 
The results for MTT assay, following cells exposure to NM-212 during 24 hours are presented 
in figure 4.5. Although absorbance readings were made before and after microplates centrifugation (to 
reduce NPs interference in the colorimetric readings), the results before the centrifugation are the only 
ones here presented because any differences were detected between the two colorimetric readings. 
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Figure 4. 5- Results for cell viabiliy after 24 hours of cells exposure to NM-212. 
As can be observed, NM-212 did not have significant effects on cell viability (p=0.35) and no 
dose response could be detected. Positive control (SDS) led to a marked decrease in cell viability up to 
34.72±2.59. 
 
 
The clonogenic assay has a longer time of exposure and evaluates the capacity of a single cell 
to form a colony when it is exposed to NMs. The results obtained are presented in the figure 4.6. 
 
 
Figure 4. 6- Results of the clonogenic assay after 7 days cells exposure to NM-212. * Significantly different 
from the negative control (Tukey Post-Hoc test). 
Significant differences were observed in the cells viability (or the surviving fraction) when the 
concentrations of CeO2 nanomaterials increased (p=0,003). The SF of cells after exposure to the 
concentrations of 75 and 100 µg/cm2 were significantly different from those of the negative controls 
(p=0.01 and p=0.002, respectively).  However, no dose-response curve could be attributed to this NM. 
MMC induced significant decreases in SF when compared with negative control (p=0.001). 
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The results of the CBPI and RI are displayed in Figures 4.7- A and B, respectively. 
 
 
 
 
 
 
 
 
 
 
 
As can be seen, CeO2 NMs did not any variation in these indexes, irrespectively of the 
concentration tested 
A significant difference was seen in the CBPI and RI values when comparing the positive control 
(MMC) with the negative control (p<0.001 and p=0.01 respectively).  
 
 
4.1.3 Genotoxicity Assessment 
To quantify the breaks in DNA and oxidative stress arising from cells exposure to nanomaterials, 
the modified comet assay with FPG was employed with two different time points: 3 and 24 hours. The 
results are shown in Figures 4.8-A (3 hours) and 4.8-B (24 hours). 
 
 
 
 
In the Figure 4.8-A it is possible to see that there is a two-fold increase in % of DNA in tail for 
the FPG results at the highest concentrations tested, although not reaching statistical significance. 
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Figure 4. 7- A- Results of RI after 48 hours of exposure to NM-212; B- Results of CBPI after 48 hours of 
exposure to NM-212. 
 
Figure 4. 8- A- % of DNA in tail after 3 hours of cells exposure to NM-212. B- % of DNA in tail after 24 
hours of cells exposure to NM-212. 
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The exposure to the positive control (EMS) yield significant differences in DNA damage, with 
FPG (p=0.001 and p=0.002, for the experience with 24 and 3 hours exposure, respectively), or without 
FPG (p=0.015 and p=0.577, for the experience with 24 and 3 hours exposure, respectively). The values 
for % DNA in tail corresponding to EMS results are presented in table III-2 and III-4 (annex III). 
 
This cytokinesis-blocked micronucleus assay is more accurate to identify permanent damages in DNA 
cells (comparing with Comet assay), that results from DNA breakage or loss and remains in daughter 
cells after division. The results for this assay are presented in Figure 4.9. 
 
 
 
 
 
Figure 4. 9- Micronucleated binuclated cells after 48 hours of exposure to NM-212. In CBMN 
assay the micronucleus frequency was not increased when the cells were exposed to CeO2 
nanomaterials. The statistical analysis did not show significant differences between any of the NM 
concentrations tested and the negative control. MMC, used as a positive control, significantly increased 
the MN frequency over the negative control leading to a value of MNBNC of 21.96±8.43 (p<0.001). 
 
 
 
4.2 Titanium dioxide nanomaterials  
4.2.1. Characterization of nanomaterial dispersion in the 
culture medium  
As shown in Figure 4.10 the dispersion of NM-100 was achieved and the range of size 
distribution is relatively low (PdI= 0.18±0.02) and Zav value of 239.5±5.95 nm. These values are similar 
to the NANoREG benchmark values of batch dispersions – 235.9 nm for Zav and 0.16 for PdI. 
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Figure 4. 10- Size distribution of the batch dispersion of NM-100 (2.56 mg/mL) soon after the 
sonication in BSA water 0.05%. 
  
 
 
                      
Figure 4. 11- Size distribution of NM-100 for concentration 3.2 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
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Figure 4. 12- Size distribution of NM- 100 for concentration 32 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
 
Figure 4. 13- Size distribution of NM- 100 for concentration 240 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
This nanomaterial remained relatively stable over time for the three tested concentrations. 
Nevertheless, there are some particularities that should be noted as the light increase of PdI and Zav 
for concentrations of 3.2 and 32 µg/mL after 7 days in the culture medium, which possibly means an 
increase in size distribution and particle size (probably derived from particle agglomeration/aggregation). 
This observation can also be noticed from the graphs when a secondary peak is present after the main 
peak. 
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For NM-101, the Zav is higher than for NM-100, with a value of 487.1±13.5 nm and a PdI of 
0.35±0.03. These data present an unimodal size distribution, since PdI value is relatively small. Values 
are consistent with NANoREG benchmark values (0.28 and 426.2 nm for PdI and Zav values, 
respectively). 
 
 
Figure 4. 14- Size distribution of the batch dispersion of NM- 101 (2.56 mg/mL) soon after 
sonication protocol in BSA water 0.05%. 
 
Figure 4. 15- Size distribution of NM- 101 for concentration 3.2 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
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Figure 4. 16- Size distribution of NM- 101 for concentration 32 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
 
 
Figure 4. 17- Size distribution of NM- 101 for concentration 240 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
 
When the batch dispersion of NM-101 was diluted in culture medium, it was observed, through 
DLS results, that the Zav decreased and the PdI increased, showing that the dilution in such medium 
affected the size distribution. After 24 hours the concentration 3.2 µg/mL is the most critical one because 
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the correspondent PdI is 0.94, compatible with a multimodal distribution. Also, measurements referent 
to concentrations of 32 and 240 µg/mL indicate higher particle size immediately after sonication but in 
the other  tested time points the particle size and PdI decreased (peak shifted to the left), suggesting 
the deposition of the larger particles with the incubation period and a stable dispersion of the smallest 
NPs.  
 
 
 
 
4.2.2 Cytotoxicity Assessment 
The results of the MTT assay in A549 cells after the exposure to titanium dioxide nanomaterials 
during 24 hours are presented in Figure 4.18. 
 
 
Figure 4. 18- Results for cell viabiliy after 24 hours of exposure to NM-101 and NM- 100. 
 
Neither NM-100 nor NM-101 caused significant decreases in cell viability, while the positive 
control decreased significantly the viability as compared to negative controls (p<0.001 and p=0.001 for 
NM-100 and NM-101, respectively). Likewise, the CBPI and RI results (figures 3.21 and 3.22 
respectively) did not show any alteration or any relevant cytotoxicity for NM-100. However it was 
possible to see a sharp decrease of these indexes for MMC (table II-3 in annex II). 
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Figure 4. 19- A- Results of CBPI after 48 hours of exposure to NM-100; B- Results of RI after 48 hours 
of exposure to NM-100. 
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4.2.3 Genotoxicity Assessment 
 
 
Figure 4. 20- Micronucleated binuclated cells after 48 hours of exposure to NM-100. The 
concentration 30 µg/cm2 does not present any bar because the number of micronuclei scored 
was 0. 
The frequency of micronuclei in binucleated cells was not significantly increased when A549 
cells were exposed to NM-100 and comparing the results of the tested concentrations with those of the 
negative control. Concerning the frequency of micronuclei following exposure to MMC, the frequency 
was 12.50±12.02 micronuclei per 1000 BNC (p<0.001).  However, not all slides were analyzed beacuse 
in higher concentrations (75 and 100 µg/cm2) the large amount of nanomaterials accumulated over the 
cells and did not allow micronucleus scoring. In the Figure 4.21 it is possible to observe some of these 
situations.  
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Figure 4. 21- Microscopical photos of A549 cells after 48 hours exposure to NM-100 (10x40). A- 
30 µg/cm2 ; B- 75 µg/cm2; C and D- 100 µg/cm2. It is visible the increase of NM when the 
concentrations increase. 
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The results of the comet assay following 3 and 24 hours cells exposure to NM-100 are 
graphically presented in Figures 4.22-A and 4.22-B . 
 
 
At 3 hours of exposure a significant overall increase in the level of DNA breaks was observed 
over the negative control both, with or without FPG treatment (p<0.0001). Pairwised comparisons 
showed that the level of DNA damage (without FPG treatment) induced by NM-100 concentrations of 
30, 75 and 100 µg/cm2 was significantly increased over the control level (p<0.001). The DNA damage 
measured after FPG treatment was significantly increased in concentrations higher than 10 µg/cm2 
(p<0.001). 
 
The best fit-model found was a linear function, but it was only possible to adjust the results 
obtained without FPG. The dose-response relationship, for 3 hours of exposure, can be described 
through the linear equation 𝑦 = 0.303𝑥 + 10.237 with R2= 0.86 (p<0.001, ANOVA test; p<0.001, t-
Student test, for the coefficients). 
 
The results for 24 hours exposure (Figure 4.22-B) similarly showed a significant increase in the 
level of DNA damage over the control for the treatment with and without FPG (p<0.001, One-way 
ANOVA test). Pairwised comparisons showed significant increases in the level of DNA damage for 
concentrations of 10, 30, 75, 100 µg/cm2 (p≤0.001) over the control, irrespectively of the FPG treatment. 
The results for 24 hours exposure without FPG can be described through the following equation: 𝑦 =
0.272𝑥 + 11.958 with R2= 0.82 (p<0.001, ANOVA test; p<0.001, t-Student test for the coefficients). The 
dose-response relationship for the results of 24 hours with FPG can be represented through a quadratic 
equation: 𝑦 = −0.005𝑥2 + 0.776𝑥 + 11.991, with a correlation R2=0.84 and significant parameters 
(p<0.001, ANOVA test; p<0.001, t-Student test).  
 
Comparing the results obtained with or without FPG, significant differences were observed after 
3h exposure for the concentrations of 3 and 10 µg/cm2 (p= 0.023 and 0.008, respectively, Student’s t-
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Figure 4. 22- A- % of DNA in tail after 3 hours of exposure to NM-100. *- significantly different from the control without 
FPG; **-significantly different from the control with FPG; B- % of DNA in tail after 24 hours of exposure to NM-100. *- 
significantly different from the control without FPG; **-significantly different from the control with FPG. 
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test) whereas at 24h exposure the only significant difference was observed for the 10 µg/cm2 (p= 0.024). 
These data are suggestive of the induction of oxidative DNA lesions under these conditions. 
For both assays, 3 and 24 hours, with and without FPG, EMS concentration showed significant 
increases in the level of DNA damage p value < 0.001.  
 
Figure 4.23 represent a microphotography of a comet formed in A549 cells after exposure to 
NM-100 (10x20). When the slides of comet assay were analyzed it was possible to observe brightest 
comets due the deposition on titanium dioxide nanomaterials (and it was for both nanomaterials, NM-
100 and NM-101). In the image below it is observable that the head of the comet is brighter than the tail.  
 
 
 
 
The results obtained from Comet assay in cells exposed to NM-101 during 3 and 24 hours are 
displayed in the Figures 4.24- A and 4.24- B. 
 
 
 
In Figure 4.24-A the results of the comet assay with 3 hours cells exposure to NM-101 are 
presented. Considering the overall results, significant increases were observed in DNA damage with or 
without FPG (p<0.001). Pairwised comparisons showed significant differences between the results 
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Figure 4. 23- Microphtography of a comet obtained after exposure to 
NM-100. 
 
Figure 4. 24- A- % of DNA in tail after 3 hours of exposure to NM-101. *- significantly different 
from the control without FPG; **-significantly different from the control with FPG; B- % of DNA in 
tail after 24 hours of exposure to NM-101. *- significantly different from the control without FPG; 
**-significantly different from the control with FPG. 
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obtained for the 75 or 100 µg/cm2 and the negative control (p= 0.003 and p=0.014, respectively), without 
FPG. Concentrations of 30, 75 or 100 µg/cm2 with FPG yielded significant increases of DNA damage 
over the negative control (p<0.001) with FPG. 
 
A dose-response relationship was detected for the results of FPG-comet assay after 3 hours of 
exposure with a linear function whose equation is 𝑦 = 0.303𝑥 + 13.694, with R2=0.87(p<0.001, ANOVA 
test;  p<0.001, t-Student test of all the parameters). On the other hand, no dose-response was 
determined for the data without FPG. 
Following the 24h-exposure, there were significant differences in the cells exposed to NM-101 
with or without FPG (p≤0.001). For this timepoint, pairwised comparisons showed significant differences 
in DNA damage after the concentrations of 75 and 100 µg/cm2 (p= 0.004 and p<0.001,), without the 
FPG enzyme, while the results with the enzyme for 30, 75 and 100 µg/cm2 showed significant increases 
in DNA damage (p<0.013). Dose-response effects were observed that corresponded to quadratic 
functions: 𝑦 = −0.004 𝑥2 + 0.667𝑥 + 10.469, R2= 0.82, without FPG (p<0.001, ANOVA test; p<0.01, 
Student’s t-test for the parameters) and  𝑦 = −0.001 𝑥2 + 0.035𝑥 + 7.547, R2= 0.82, with FPG (p<0.001, 
ANOVA; t-Student test of the coefficients are not significant). 
At both timepoints, significant increases in DNA damage were observed when using FPG assay, 
as compared to the conventional comet, at the two highest concentrations (p≤0.001), showing the 
induction of oxidative DNA lesions by NM-101. 
For both timepoints  and for both conditions, with and without FPG, the positive control- EMS 
showed significant increases in DNA damage when compared with the negative control (p<0.003). 
 
 
4.3 Barium sulphate nanomaterials 
4.3.1 Characterization of nanomaterial dispersion in the 
culture medium for NM-220 
 
 
Figure 4. 25- Size distribution of the batch dispersion of NM- 220 (2.56 mg/mL) soon after the 
sonication in BSA water 0.05%. 
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For NM-220 a homogenous batch dispersion in BSA water 0.05% was achieved The Zav 
obtained was 133.95±1.25 nm and the PdI=0.18±0.01, which is in accordance with the NANoREG 
benchmark - 118 nm for Zav and 0.12 for PdI. 
    
 
Figure 4. 26- Size distribution of NM- 220 for concentration 3.2 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
 
       
 
 
Figure 4. 27- Size distribution of NM- 220 for concentration 32 µg/mL in cell 
culture medium at 0, 24, 48 hours and 7 days after dispersion and incubation 
at 37ºC. 
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Figure 4. 28- Size distribution of NM- 220 for concentration 240 µg/mL in cell culture medium at 
0, 24, 48 hours and 7 days after dispersion and incubation at 37ºC. 
From the graphs above and the values presented in the correspondent table (annex I.4) it is 
possible to verify that the coarsest dispersion in the culture medium occurs for the concentration of 3.2 
µg/mL. The PdI values indicate a broad range of size distribution and a small particle size. However the 
PdI is smaller for concentrations 32 and 240 µg/mL when this values decrease. It is also observable that 
the nanoparticle size greatly increases for the last two concentrations, probably due the formation of 
aggregates/agglomerates. It is also easily noted from all the graphs that when concentrations rise the 
dispersions change from coarse to finest, possibly because the larger agglomerates tend to become 
deposited and the single NPs remain stably dispersed.  
 
 
4.3.2 Cytotoxicity Assessment 
The data obtained for the assay with 24 hours exposure is presented in Figure 4.29.
 
Figure 4. 29- Results for cell viabiliy after 24 hours of exposure NM- 220. 
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There were not significant differences between the negative control and the other NMs’ 
concentrations (p=0.67). However, as expected, SDS 0.01% did show significance comparing to 
negative control (p<0.001).  
Similarly, the CBPI and RI values (Figure 4.30) did not show any significant difference 
comparatively to the control value (p=0.08). The positive control decreased both indexes although not 
significantly (details in table II.3 in the annex). 
 
 
 
 
 
4.3.3 Genotoxicity Assessment 
The results for the micronucleus assays are represented in Figure 4.31. 
 
 
Figure 4. 31- Micronucleated binuclated cells after 48 hours of exposure to NM-220. 
 
The frequency of micronuclei of A549 cells exposed to BaSO4 NMs was not significantly 
increased over the control. The results for MMC showed a significance of (p<0.001). 
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Figure 4. 30- A- Results of CBPI after 48 hours of exposure to NM-220; B- Results of RI after 48 hours of 
exposure to NM-220. 
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The results of DNA breaks correspondent to NM-220 are represented in the Figures 4.32-A and 
4.32- B. Figure 4.32- A correspond to 3 hours of exposure and the Figure B corresponds to 24 hours of 
exposure. 
 
  
As can be seen, any marked increase in the level of DNA breaks was detected after 3 hours 
and 24 hours of cells exposure to barium sulphate nanomaterials. Nevertheless, a two-fold increase in 
the level of DNA damage was noted after treatment with 3 and 10 µg/cm2 (3h) or with µg/cm2 (24h) by 
the FPG-modified assay suggesting a slight induction of oxidative DNA damage. However, any 
statistically significant differences were detected both for the shorter and the longer exposure durations, 
with and without the FPG enzyme.  
Only the positive control for 3 hours of exposure without FPG showed significance (p=0.001); 
however the remaining results in tables III.1 and III.2 in the annex III show an increase in DNA breaks 
after EMS exposure.   
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Figure 4. 32- A- % of DNA in tail after 3 hours of exposure to NM-220; B- % of DNA in tail after 24 
hours of exposure to NM-220. 
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4.4. Overview of the cytotoxicity and genotoxicity 
assessment of the tested NMs 
 
 
In Table 4.1. an overview of the assays performed as well as the results obtained is presented. 
 
Table 4. 1- Overview of the results of cyto- and genotoxicity obtained for NM-212, NM-101, NM-
100 and NM-220. 
 NM-212 NM-101 NM-100 NM-220 
MTT assay - - - - 
Clonogenic assay + +* -* -* 
CBMN assay - -* - - 
Comet assay- 3h - + + - 
Comet assay – 3h with FPG - + + - 
Comet assay- 24h - + + - 
Comet assay- 24h with FPG - + + - 
- negative results; + positive results; * done by another team member 
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5. DISCUSSION  
 
The synthesis and production of metal oxide NPs are consistently expanding due to their 
distinctive physico-chemical characteristics and increasing industrial and medical applications (Saquib 
et al. 2012). This has evoked serious concerns about their potential impact on the environment and 
human health and constitutes an additional challenge for the regulatory authorities (Saquib et al. 2012; 
Park et al. 2008). 
Current knowledge is still unsystematic, not well understood and restricted to particular aspects 
of NPs' capability to induce toxic and pathological processes or to alter the structure and function of 
different cell types (Pagliari et al. 2012; Park et al. 2008). Recent data have suggested that nanoparticles 
exposure is often associated to increases in cellular ROS, that can originate at the particle surface as a 
result of the material semiconductor or electronic properties as well as the capability of some materials 
to perturb electronic transfer processes in cell such as in the mitochondrial inner membrane (Rim et al. 
2012; Park et al. 2008).  
To date, there are few studies directly investigating the toxicity of these nanoparticles and 
making a comparison of their subsequent toxic effects. It is known that cellular effects of nanoparticles 
are strongly dependent on chemical and structural characteristics, surface/mass ratio, solubility, and 
shape (Qiang et al. 2013). Nanomaterials are composed of primary and agglomerated particles that can 
vary in size  (actually, the sizes of the particles in suspension are different from the original primary size) 
shape, charge, crystallinity, chemical composition and other characteristics, and this variety will increase 
even further in the future  (Braakhuis et al. 2014; Qiang et al. 2013). Thus,  an adequate risk assessment 
of nanomaterials requires information on both the exposure and hazard of their component particles 
(Braakhuis et al. 2014).  
Inhalation is considered to be an important route of exposure to nanoparticles, especially in 
occupational and consumer settings (Braakhuis et al. 2014). The most reported effect is pulmonary 
inflammation, largely indicated by an influx of neutrophils that can be observed in the broncho-alveolar 
lavage fluid in rodents and the induction of inflammatory cytokines in in vitro lung models (Braakhuis et 
al. 2014). Comparison across studies is often difficult due to the use of different experimental protocols 
and choice of endpoints, which largely influences the results.  
Another important point to underline is that after deposition, some agglomerates can 
disagglomerate into the primary particles, or primary particles can agglomerate after contact with the 
protein-rich cells culture medium or with the lung lining fluid in vivo (Braakhuis et al. 2014). A 
deagglomeration mechanism, enhanced by the acidic environment close to the lipid nuclear membrane, 
is proposed to explain those findings. Upon internalization in the nucleus, the nanoparticles 
reagglomerate and are observed as larger agglomerates under electronic microscopy. These findings 
are important for understanding the toxicity of nanoparticles, and provide evidence of the possibility of 
direct (or short-distance) interactions between nanoparticles and DNA as a cause of genotoxicity 
(Ahlinder et al. 2013). 
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5.1 The analysis of the NMs dispersion 
To avoid aggregation and obtain stable suspensions, NMs are usually sonicated and well 
dispersed before the assays. 
In this work a general increase in the primary size of the nanomaterials was observed when 
they entered into contact with aqueous medium. This observation has been reported in other works and 
it was found that metal oxides adsorb medium components such as Ca2+ and serum proteins, which 
then affects their agglomeration/aggregation state and size distribution (Panas et al. 2014). Hence, 
agglomeration commonly occurs when particles are introduced into the aqueous medium (Shukla et al. 
2011). Although all nanomaterials initially adsorb similar amount of serum from the media, the total 
amounts of adsorbed protein decreased with time and the extent of protein desorption was material 
dependent (Panas et al. 2014; Konduru et al. 2014). The size of the aggregates seemed to be 
concentration-dependent, i.e., the higher the concentration, the larger the hydrodynamic diameter 
(Panas et al. 2014; Konduru et al. 2014). This suggests that only a fraction of the nanoparticles exposed 
to the cells exist as single particles, given that NPs  tend to aggregate in the culture medium (Eom and 
Choi 2009). 
Due to the adsorption of medium components at the NPs surface forming the so-called protein 
corona, the NPs acquire a secondary size and also secondary physicochemical properties (Bruinink, 
Wang, and Wick 2015). However, despite the formation of aggregates, the NPs still are able to exert 
toxicity. It was demonstrated that aggregates of TiO2 NPs (1.44 μm) have been more toxic than similarly 
sized aggregates of their larger counterparts (Johnston et al. 2009). It was also demonstrated the ability 
of CeO2 NPs to form aggregates/ agglomerates (Bruinink, Wang, and Wick 2015). 
 
 
5.2 Cytotoxicity and genotoxicity of CeO2 nanomaterials 
In this work two different cytotoxicity assays were performed. The colorimetric assay, MTT, had 
a time of exposure of 24 hours and did not show any decrease in cellular viability following cells exposure 
to CeO2, indicating that these NPs do not interfere with the mitochondria function. Likewise, replicative 
indexes- RI and CBPI- from the CBMN assay (48h exposure) also did not show cytotoxic effects. 
However, the results of the clonogenic assay, where the cells had a more prolonged exposure – 7 days 
- did show a decrease in the capacity of A549 cells to form colonies in a concentration-dependent 
manner. A possible explanation for the cytotoxic results obtained in the later assay is the that CeO2 may 
produce ROS leading to oxidative stress and damaging the cellular membrane through lipid 
peroxidation, thus preventing cells proliferation (Kim et al. 2010; Mittal & Pandey 2014). Another 
hypothesis is that cell death induction could be due to dissolution and release of the metal ions in the 
culture medium, as has been described for other metallic NPs. However, CeO2 NPs do not dissolve in 
medium and so their toxicity is due to NPs and not to cerium ions (Mittal & Pandey 2014).  
On the other hand, the document from JRC, that describes the physico-chemical properties of 
the NM-212 under study, reports that this specific NM has 93.1% of Ce4+ and 6.9% of Ce3+ and the NPs 
are cubic. An in vitro study tested different forms of CeO2 NPs: rod-like, octahedron-like and cube-like 
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nano-CeO2. Rod-like and octahedron-like protected and inhibited DNA damage by scavenging ·OH, but 
cube-like nano-CeO2 did not eliminate ·OH (L. Wang et al. 2015). This suggests that the form, superficial 
area and consequent different arrangement and ionic state also could be an important influence 
triggering or protecting against the cytotoxicity. 
The present results agree with those of Kim et al. (2010) Kim et al. (2010) that showed no 
cytotoxic effects of a high concentration (1000 µg/mL) of CeO2 NPs (15 and 30 nm) in A549 cells (WST-
1 assay), while a long-term exposure to a concentration range from 0.5 to 500 µg/mL, dramatically 
reduced the colony number, as assessed by the clonogenic assay. The authors associated this 
reduction in the colony forming ability to the significant membrane damage observed by the LDH 
Leakage Assay in the same cell line However, this study also tested CeO2 in L-132 cells (normal human 
lung epithelial cells) showing no release of LDH (Kim, Baek, and Choi 2010). On the other hand, 
oxidative stress was revealed by the increase of ROS and lipid peroxidation levels and by reduction of 
the GSH levels (Kim, Baek, and Choi 2010).  Another study using CeO2 NPs (8-20 nm) in concentrations 
from 1 µg/mL to 100 µg/mL in A549 cell line during 3, 6, 24, and 48 hours, concluded that CeO2 NPs 
got internalized in cells and produced increased amount of ROS, which contributed to extensive DNA 
damage and perturbation of the cell cycle, in parallel with an increasing number of apoptotic cells (Mittal 
and Pandey 2014). Another study of CeO2 NPs (20 nm) in the A549 cell line, showed a decrease of 
cells viability for concentrations of 3.5, 10.5 and 23.3 µg/mL, after 72 hours exposure (colorimetric SRB 
assay and the LDH leakage assay) (Lin et al. 2006). Furthermore, cytotoxicity assessment by the 
propidium iodide (PI) uptake assay, and the trypan blue assay showed a decrease in viability after 24 
and 48 hours for concentrations of 25, 50 and 100 µg/mL (Mittal and Pandey 2014).   
Other studies were performed with the aim of assessing the effects of different sizes of CeO2 
NMs in pulmonary cells. Overall, the effect of size is still unclear for CeO2 NPs since there is not a 
consensus about the results obtained until the present. A study in Beas-2B (human bronchial epithelial 
cell), using CeO2 NPs with different diameter sizes of 15, 30, 45 nm suggested that 1 mg/L of CeO2 
nanoparticles, during 24 hours, may exert their toxicity through oxidative stress, as they cause significant 
increases in the cellular ROS concentrations, although a quantification analysis did not indicate any 
size-dependent effect (Eom and Choi 2009). The MTT assay was performed in Beas-2B treated with 
10, 20, and 40 µg/ml of CeO2 NPs (30 nm) for 24, 48, 72, and 96 hours. The results of viability test 
showed that toxicity of 30 nm cerium dioxide nanoparticles appeared in the cells treated with 10 µg/mL 
and higher concentrations at 24 h exposure.  Different sizes of cerium oxide nanoparticles were also 
compared through this toxicity test but no statistically differences were found among groups treated with 
15, 25, 30, and 40 nm-particles. It was also reported the induction of ROS and decrease of intracellular 
GSH in cultured Beas-2B cells (Park et al. 2008). These authors tried to justify the results in Beas-2B 
cells reporting that the particle that they prepared do not have the same arrangement of the 
nanoparticles used in other studies showing anti-oxidant properties, and do not have the same Ce3+ 
ionic state enough to scavenge the oxygen radicals. In fact, there are some studies already available 
that report the effect of the size in the relative amount of cerium ions Ce3+ and Ce4+ saying that, in 
general, the fraction of Ce3+ ions in the particles increases with decreasing particle size (Xu & Qu 2014; 
Schubert et al. 2006). Concerning what was explained above about the low amount of Ce3+ ions in the 
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NPs herein studied, this could be another factor that justifies the cytotoxicity obtained in the clonogenic 
assay. Moreover, in cancer cells (e.g., A549 cells), the high metabolism puts high levels of stress on the 
endosomal system. This can result in higher uptake of NPs, or even in slight differences in endosomal 
pH levels. The pro- or anti-oxidant roles of CeO2 NPs are linked to the surrounding pH. In acidic 
environments, CeO2 NPs favor the scavenging of superoxide radical over hydroxyl peroxide resulting in 
accumulation of the latter whereas in neutral pH CeO2 NPs scavenge both. The differences in the 
intracellular microenvironment of cancer cells and normal cells can thus lead to different cellular 
responses to CeO2 NPs (Franchi et al. 2015).  
 
The evaluation of the toxicity of this nanomaterial has been performed and assessed in other 
cell lines from different organs. An in vitro study in human neutrophils demonstrated the release of some 
indicators of inflammatory process with the degranulation of these cells, when exposed to CeO2 NPs 
(Babin et al. 2013). Also, in human hepatocarcinoma cells (SMMC-7721 cell line) CeO2 nanoparticles 
caused morphological damage, reduced cell viability and induced significant apoptosis and suggested 
that CeO2 nanoparticles could induce oxidative stress (Cheng et al. 2013). MTT assay in ECs revealed 
that nanoceria were cytotoxic to ECs at all tested concentrations (5, 10, 20, and 40 μg/mL) and exposure 
times (24, 48, and 72 hours) (Chen et al. 2013). Negative results were also obtained by the MTT assay 
in NCTC2544 cells demonstrating that CeO2 are not toxic at the highest concentration tested (80 µg/mL) 
(Boutard et al. 2013).  
 
In vivo studies have also been performed in order to try to correlate the results of the in vitro 
tests. An in vivo study in rats, through inhalation of 15-30 nm CeO2, demonstrated a significant decrease 
in cell viability of bronchoalveolar lavage fluid (BALF) of the exposed rats up to 14 days post inhalation 
exposure period of 641 mg/m3, suggesting that nanoparticles induced apoptosis and this was further 
supported by elevated levels of LDH activity in BALF. The increase in lipid peroxidation resulted in cells 
membrane damage as indicated by LDH release. These results suggest that acute exposure to CeO2 
NPs through inhalation route may induce cytotoxicity via oxidative stress and may lead to a chronic 
inflammatory response (Srinivas et al. 2011). A study with CD1 mice that consisted in inhalation 
exposure of 2 mg/m3 of CeO2 NPs, with 45 nm of diameter, for 28 days demonstrated that it can induce 
inflammatory response and oxidative stress. In this publication it is also reported that the particles once 
deposited are hard to be cleared and may provoke a range of long term toxicological effects (Aalapati 
et al. 2014). It was also demonstrated in an in vivo study with rats that CeO2 NPs (6.4–14.8 nm) with 
final concentrations at 0.15, 0.5, 1.0, 3.5 or 7 mg/kg body weight through intratracheal instillation up to 
28 days post-exposure that this nanoparticles induce a range of mediators involved in lung inflammation 
and pulmonary fibrosis (Ma et al. 2012).  
Regarding the antioxidant/oxidant effect of ceria nanoparticles, it seemed that ceria 
nanoparticles have different modes of action according to the types of cells. It is possible that some 
cellular physiology related with antioxidant effects among the different types of cells, or some media 
environment may be one of the differences in exerting cytotoxicities (Park et al. 2008). 
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As to the genotoxic effects of CeO2 in A549 cells, the FPG-Comet assay results showed a two-
fold increase in the level of DNA damage following 3 hours exposure to the two highest CeO2 NPs 
concentrations, compared to the control, although no statistically significant differences were found. This 
observation suggests a mild and transient induction of oxidative DNA damage. At 24 hours exposure 
the results were all negative. The results from the CBMN assay with 48 hours of exposure did not show 
any increase in the number of MN. Thus, from these data it can be concluded that the CeO2 under study 
is not genotoxic. In contrast to the numerous studies on CeO2 cytotoxicity there are only a few studies 
assessing its genotoxicity. A549 cells exposed to 25 µg/mL, 50 µg/mL, and 100 µg/mL concentration of 
CeO2 NPs (8-20 nm) for 6 hours exhibited a significant induction in DNA damage compared to control 
cells as evidenced by the % tail DNA in standard alkaline comet assay. Moreover, the values for % tail 
DNA in the FPG-modified Comet assay were significantly higher than those of the standard alkaline 
comet assay (Mittal and Pandey 2014). On the contrary, a study performed in human lens epithelial 
(HLE-B3) cells with 5 µg/mL and 10 µg/mL of CeO2 NPs (~6 nm) during 24 hours did not show DNA 
damage when the alkaline comet assay was performed (Pierscionek et al. 2010). The assumption that 
the different effects of CeO2 are dependent of the NM physico-chemical properties, e.g., shape and the 
surface content of Ce3+ and Ce4+ ions and also of the cell type, is evidenced in these and other studies. 
Furthermore, the complex balance between the anti-oxidant properties of CeO2 NMs and the oxidative 
stress induction reported in some studies makes it difficult to predict whether ROS generation might 
have been expected to induce DNA damage and subsequent chromosome breakage and micronucleus 
induction. In line with the present results, an in vivo study performed during 3 and 6 months did not show 
genotoxicity in rats (erythrocytes and leukocytes) through alkaline comet assay and micronucleus assay 
after exposure to NM-212 (Cordelli et al. 2016). 
 
 
 
5.3 Cytotoxicity and genotoxicity of TiO2 nanomaterials 
In this work two different TiO2 NMs were tested, presenting different sizes, surface areas and 
coatings. As presented in Table 3.1 (chapter Materials and Methods), NM-101 has a smallest size and 
consequent higher superficial area than NM-100 and both NMs have anatase crystalline phase.  
Relatively to cytotoxicity assessment, both NMs did not show cytotoxicity by the MTT assay. RI 
and CBPI obtained from CBMN assay performed with NM-100 also did not reveal any significant 
alterations and the results reported by Santos (2015) also did not reveal any alteration in RI and CBPI 
for NM-101. Even though the uptake of the TiO2 NPs was not investigated in the present study, several 
works have already demonstrated that A549 cells are able to internalize TiO2 NPs of different sizes and 
crystalline phases (Moschini et al. 2013; Aueviriyavit & Phummiratch 2012;  Franchi et al. 2015). Thus, 
an hypothetical lack of these NPs uptake can be discarded. 
Some studies have already assessed the toxicity of diverse TiO2 NPs in the A549 cell line and 
the results are often contradictory. In agreement with the present data, another study (using the WST-1 
assay) performed in A549 and L-132 cells (from normal human lung epithelia) showed that TiO2 NPs 
did not significantly inhibit cell proliferation of both cell types up to the highest concentration tested (1000 
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µg/ml), after 72 hours of exposure. However, TiO2 reduced about 20% colony formation at the 
concentration range of 0.5 to 500 µg/ml in A549 cell line (Kim, Baek, and Choi 2010). These results are 
similar to those obtained in this work for MTT assay, where it was not observed any decrease in viability 
and for clonogenic assay when Santos (2015) exposed A549 cell line to NM-101 and verified an increase 
in cytotoxicity starting in 30 µg/cm2 (figure IV.2, annex IV). The ability of NM-101 (5 nm, sylane coated) 
to impair cells proliferation was further confirmed by our team; NM-100 (20-100 nm, uncoated), in turn, 
did not reveal significant cytotoxic potential by the clonogenic assay (figure IV.1, annex IV).  Other 
studies using different cytotoxic assays (MTT, neutral red, PI staining and LDH test) to screen 
cytotoxicity after exposure to TiO2 NMs (~50 nm) in a range concentration from 1 to 100 µg/mL during 
3 and 24 hours in A549 cells showed neither significant reduction in cell viability nor increase in 
intracellular ROS production (Moschini et al. 2013). Similar results were obtained even for the pro-
inflammatory response (IL-8 release) and for the induction of cell oxidative damages (Moschini et al. 
2013). The production of ROS is an important endpoint to evaluate since nanoparticles exposure is often 
associated with increases in cellular reactive oxygen species (ROS), as mentioned above. Although this 
study did not show oxidative damages there are studies in literature that reveal the increase of ROS or 
oxidative stress in a concentration- and time-dependent manner from TiO2 NPs (Kim et al. 2010; 
Aueviriyavit & Phummiratch 2012; Jugan et al. 2012; Andersson et al. 2011; Shukla et al. 2013). 
In another work, when the A549 cell line was exposed to a concentration range from 0 to 200 
μg/mL of TiO2 NPs (5 nm) for 24, 48, and 72 hours to assess cell viability through MTT assay, TiO2 
anatase NPs strongly inhibited A549 cell proliferation in a dose- and time-dependent manner (Wang et 
al. 2015). Also MTS assay showed a dose-dependent decrease in cell viability after 24 hours for the two 
highest concentrations tested (5 to 500 μg/mL) of the anatase form of TiO2 NPs (20 nm) in A549 cells 
(Aueviriyavit & Phummiratch, 2012). Another assay in A549 cells showed a dose-dependent decrease 
in cell viability as well as in ATP levels, demonstrated by CCK-8 assay  after exposure to TiO2 NPs (20-
50 nm) in a concentration range from 50 to 300 µg/mL, for 4 hours. In Beas- 2B, TiO2-NP did not induce 
cytotoxic effects up to a tested concentration of 50 μg/cm2 (Bhattacharya et al. 2009). MTT and NRU 
assays exhibited cytotoxicity after 24 and 48 hours at the highest concentrations (40 and 80 µg/mL), 
while no significant cytotoxicity was detected after 6 hours exposure in human liver cells (HepG2) 
(Shukla et al. 2013).  
 
In this work the cytotoxicity of TiO2 could be related with some NPs characteristics like coating, 
since NM-100, without coating did not revealed cytotoxicity in the cell proliferation assay while the coated 
NM-101 induced a decrease of the colony formation ability in the same assay. The coating of NMs could 
be determinant in the effects of NMs in the cells because it will favor (or not) some biomolecules to bind 
to NMs, forming the corona protein and thus modifying their reactivity and ability to be uptaken by cells. 
A smaller NP have a higher surface area, which means that this nanomaterial is more reactive. 
NM-101 has a higher superficial area than NM-100 and this characteristic could also explain the results 
obtained in the clonogenic assay. 
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Sometimes the discrepant results are also justified with the different sizes, crystalline phases, 
times of exposure, endpoints assessed or cell lines. There are already some studies where authors try 
to understand the influence of size and crystalline phase on cytotoxicity.  A study in A549 cell line with 
different sizes (12-140 nm) and crystalline forms (rutile and anatase) of TiO2- A12, - A25,- A140, -R68, 
-R20-  (A means anatase, R means rutile and the following number is the diameter in nanometer), was 
performed. The assays were conducted in a range concentrations of 1–200 mg/mL of NP suspensions. 
In the MTT assay (4-48 hours of exposure) TiO2-NPs, both rutile and anatase, with diameters lower than 
100 nm exerted more pronounced toxic effects than TiO2-NPs with diameters higher than 100 nm (Jugan 
et al. 2012). Hence, in this study the characteristic that most influenced the results was the size of NP. 
Other studies showed that the anatase phase is more toxic than the rutile and so the crystalline phase 
can be an important feature (Chen et al. 2014;  Wang et al. 2015; Hamzeh & Sunahara 2013; Hsiao & 
Huang 2011; Sayes et al. 2006; Demir et al. 2015).  A study performed in the A549 cell line, related 
cytotoxicity and inflammation from different crystalline phases and surface areas of TiO2 NMs. The 
cellular responses exhibited dose- and time dependent behavior. The extent to which nanoscale titania 
affected cellular behavior was not dependent on sample surface area because smaller nanoparticles 
had effects comparable to larger nanoparticles. What correlated strongly to cytotoxicity, however, was 
the phase composition of the nano-scale titania. Anatase TiO2 was more toxic than an equivalent 
sample of rutile TiO2. The most cytotoxic nanoparticle samples were also the most effective at 
generating reactive oxygen species (Sayes et al. 2006).  
 
Besides the cytotoxicity tests that have been presented in this discussion there are other 
features or endpoints that could have been assessed to better understand the effects of NMs in the 
cells. The morphology of the cells was one of these characteristics. In A549 cells typical apoptotic 
morphological changes consisting of cell shrinkage in response to TiO2 NP were observed by others 
authors in a concentration-dependent manner, which suggested that TiO2 NPs induce apoptosis and 
increases the proportion of G2/M phase cells (Wang et al. 2015). This observations could also explain 
the reduction of cell proliferation in the clonogenic assay for NM-101. The cells remain in phase G2 
(checkpoint of cellular cycle) instead of going to a cellular division (mitosis). In human fetal lung 
fibroblasts, at the lower dose (0.25 mg/mL), the morphology of the cells appeared to be altered and with 
increasing doses cell morphology was destroyed (Z. Qiang et al. 2013). Significant cytotoxicity, 
intracellular ROS generation, and to some extent G2/M cell cycle arrest were induced at the above 
specified treatment dose, and attributed to TiO2 NPs mediated oxidative stress in the WISH cells (Saquib 
et al. 2012). Also, in untransformed human fibroblasts, TiO2 NPs were found to induce apoptosis at later 
time points, as a delayed effect of cellular NP exposure (Franchi et al. 2015).  
 
In addition, in vivo studies have also been performed and demonstrated that when rats were 
submitted to 10, 50, 200 mg/kg of TiO2 NPs once a day for 30 consecutive days these NPs could induce 
DNA double strand breaks in bone marrow cells after oral administration, despite that no chromosomes 
and mitotic apparatus damage were found. The formation of gamma-H2AX foci, the biomarker of DNA 
double strand breaks (DSB) formation, detected that TiO2 NPs induced genotoxic effects, as also 
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verified by the comet assay when showed an increased in DNA breaks despite no induction in 
micronuclei was observed (Chen et al. 2014). On the other hand another in vivo study in rats indicated 
that a single intratracheal instillation of anatase TiO2 nanoparticles (5 mg/kg) or repeated intratracheal 
instillation (1 mg/kg) once a week for 5 weeks did not induce DNA damage, in the lungs in rats but 
induced an inflammatory response with the presence of macrophages and neutrophils (Naya et al. 
2012). 
 
In the present study, the comet assay was performed to assess DNA breaks in A549 cells after 
exposure to NM-101 and NM-100. In addition, the CBMN assay was conducted to evaluate the induction 
of chromosome breaks after cells exposure to NM-100. Using the Comet assay a concentration-
dependent increase in DNA breaks was observed for NM-100, which was accentuated following the 
treatment with the FPG enzyme. Cells treatment with NM-101 also resulted in a significant increase in 
the level of DNA damage for the two highest concentrations tested (plus FPG treatment). Santos (2015) 
has previously performed the Comet assay at the same conditions and also verified a significant 
increase in DNA damage 24 hours after exposure to NM-101 (without FPG). Another study in A549 cells 
with different concentrations of TiO2 NPs (0 to 52 μg/cm2) for 48 hours reported that the percentage of 
tail DNA was significantly increased with the increase in dose of TiO2 NPs, which suggested the 
induction of DNA damage in a dose-dependent manner (Wang et al. 2015). In a study performed with 
different sizes and crystalline phases of TiO2 NPs, the authors related an increase in the level of DNA 
breaks after 4 hours of exposure and a further increased after 24 hours, but it was significant only after 
exposure to TiO2-A12, -A25 and -R20, but not to TiO2-R68 and -A140. However, after 48 hours the 
frequency of breaks drastically decreased in exposed cells (Jugan et al. 2012). Other study revealed 
that TiO2 NPs exposure only increased the percentage of DNA in the tail at the concentration of 100 
µg/mL and at 24 hours in V79 cells (Chen et al. 2014). Induction of DNA breaks was obtained with nano-
TiO2 anatase, but only at the highest dose tested (100 mg/mL) in HEK293 (human embryonic kidney) 
and NIH/3T3 (mouse embryo fibroblast cells) cell lines (Demir et al. 2015).  The exposure for 6 hours 
has also induced a significant level of DNA damage at a concentration of 20 µg/mL in WISH cells (Saquib 
et al. 2012).  
Our results in comet assay can be related with the crystalline phase, anatase, which was 
previously reported in this work, as the more toxic and so the most effective at generating reactive 
oxygen species which can be the cause of DNA breaks    
 
For the CBMN assay, no significant differences in the mean frequency of MNBNC were 
observed in the present work. Similarly, no induction of MNBNC has been previously reported by Santos 
(2015) after NM-101 treatment but a reference to the difficulty in the slides scoring due to deposition of 
NMs on the cells was found. A study in A549 cells did not report differences for CBPI after exposure to 
TiO2 NMs (7- 9 nm). The authors referred that the results from CBMN assay are not available because 
the MN were obscured by NM agglomerates over the cells and thus could not be scored (Corradi et al. 
2012). In HepG2 a significant induction in micronucleus formation was observed at 20 µg/mL of TiO2 
NPs (30-70 nm). However, further treatment with higher concentrations (40 and 80 µg/mL) showed a 
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decrease in the micronucleus formation. The authors associated these results in the micronucleus 
frequency also with the accumulation of TiO2 NPs on prepared slides, which hinders the counting of 
micronucleus (Vallabani et al. 2014).  In another study, TiO2 NPs induced an increase in the number of 
micronucleated cells at 20 µg/mL. However, with further increasing concentrations (40 and 80 mg/ml), 
the micronucleus formation decreased (Shukla et al. 2013). 
 
In other studies, when the MN assay was used to demonstrate the clastogenic/ aneugenic 
potential of nano-TiO2, significant increases in the frequency of MNBNC were observed in the two cell 
lines (HEK293 and NIH/3T3), but only at the highest tested dose (1000 mg/mL) and anatase form (Demir 
et al. 2015). Also, Tavares et al. (2014) reported a significant increase in the micronucleus frequency in 
human lymphocytes after exposure to TiO2 anatase (NM–102). It has been reported that the induction 
of micronucleus by nano-TiO2 is affected by the characteristics of the culture medium, getting positive 
results only with medium that facilitates the lowest amount of agglomeration. Our observations also 
suggested a high agglomeration of TiO2 when the slides were analyzed although the dispersion results 
seemed good. This would explain, in part, some of the negative results reported in the micronucleus 
assay by several authors. 
No other mechanism out of the oxidative damage has been proposed to explain the ability of 
nano-TiO2 to induce micronuclei and, as consequence, the observed increase of micronuclei would be 
the result of chromosome breaks (Demir et al. 2015). 
 
The results of CBMN assay are inconclusive since the preparations from the cells subjected to 
the highest concentrations could not be analysed. On the other hand, it was clear the induction of DNA 
breaks, by the comet assay, for both nanomaterials. 
 
 
 
5.4 Cytotoxicity and genotoxicity of BaSO4 nanomaterials 
In respect to the cytotoxicity assessment, the MTT assay and replication indexes (RI and CBPI) 
did not show decrease in cell viability. Also comet and CBMN assays did not reveal any genotoxicity. 
As already said there are not many studies reporting the toxicity of barium sulphate NPs. To the 
best of our knowledge, no in vitro studies were published about the toxicity of this NM. There are only 
some reports about in vivo studies in rats or mices. These studies demonstrated that 3 or 6-month 
inhalation exposure to 50 mg/m3 BaSO4 NM-220 did not elicit genotoxicity in either the alkaline Comet 
assay or the micronucleus test, in rats (Cordelli et al. 2016). Another study examined the effects of short-
term (4-week) and subchronic (13-week) inhalation exposure and a single IT instillation of BaSO4 NPs 
in rats. Data showed that inhaled BaSO4 NPs elicited minimal pulmonary response and no systemic 
effects. Four weeks of inhalation of 50 mg/m3 BaSO4 resulted in no pulmonary toxicity by 35 days post-
exposure. The study underscores the high Ba bioavailability and clearance of BaSO4 NPs deposited in 
the lungs. Unlike CeO2 and TiO2, BaSO4 NPs are retained to a lesser extent in the lungs after inhalation. 
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Even at lung burdens, similar to CeO2 and TiO2, BaSO4 NPs cause lower pulmonary toxicity and 
biopersistence (Konduru et al. 2014). 
Although these results are from in vivo experiments, they are in accordance with those obtained 
in this work for A549 cells, where it was not detected cytotoxicity, DNA or chromosomes breaks. Thus, 
for a non-toxic NM, a good in vitro – in vivo correlation was found, i.e., the in vitro results could have 
predicted the effects observed in vivo. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
58 
 
6. CONCLUSION 
 
This study was aimed at characterizing the potential toxicity of different nanomaterials from the 
group of poorly soluble particles, CeO2, TiO2 and BaSO4 NMs in an alveolar cell line. 
As summarized in Table 4.1 CeO2 NM was cytotoxic after a long-term A549 cells exposure but 
did not reveal toxicity for a short-term exposure, as assessed by the MTT assay. No genotoxicity was 
detected under the tested conditions.  
 
Further ongoing assays, using other in vitro and in vivo systems to test the genotoxicity of this 
NM, will improve the knowledge base for the evaluation of genotoxic risks associated with this NM. 
Because nano- CeO2 is being studied to be employed in medical applications, due to its antioxidant and 
protective effects, it is important to try to understand and distinguish what causes the adverse effects 
and the beneficial effects in order to drive the synthesis of safest nano-CeO2 while preserving its 
antioxidant beneficial effects. 
 
Both TiO2 NMs showed genotoxicity through the comet assay and these results are supported 
by many publications that report the capacity of some TiO2 NPs, mostly anatase TiO2 NPs, to interfere 
with the cells’ genetic material and consequently, having the potential to be mutagenic and carcinogenic.  
Studying TiO2 NMs with different physico-chemical properties highlighted the importance of 
some characteristics, e.g., coating and surface area in relation to the possible observed effects.  
Although TiO2 NPs are approved by FDA to be used in cosmetic products (and others), 
concerning the results here presented and other publications some applications and products where 
nano- TiO2 is present should be revised.  
 
BaSO4 NMs have shown some amazing applications in the medical field, and although the lack 
of toxicity studies for this NPs, it seems to be one of the less toxic NMs, as proved in this work and in 
the publications where in vivo tests were carried out. 
 
Further studies, focused in different properties of the same NM, in different cell lines, in vitro as 
well as in vivo approaches will contribute to understand the main characteristics that determine their 
toxicity, allowing a ‘‘safer-by-design’’ approach. 
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8. ANNEXES 
 
ANNEX I - DLS Analysis 
 
 
Table I.1 - Results from DLS analysis for NM-212 in the culture medium for concentrations 3.2, 32 and 240 µg/mL 
at 0, 24, 48 hours and 7 days. 
 
ND- not done. 
 
Table I.2 - Results from DLS analysis for NM-101 in the culture medium for concentrations 3.2, 32 and 240 µg/mL 
at 0, 24, 48 hours and 7 days. 
 
 Concentration 3.2 µg/mL Concentration 32 µg/mL Concentration 240 µg/mL 
Time PdI±SD Z Average±SD PdI±SD Z Average±SD PdI±SD Z Average±SD 
0 hours 0.6±0.11 277.95±117.05 0.4285±0.08 534.55±237.65 0.32±0.06 499,9±5.7 
24 hours 0.94 64.09 0.42 179.1 0.19 188.5 
48 hours 0.22 165.1 0.23 197 0.16 187.2 
7 days 0.16 169.5 0.12 194.2 0.14 163.3 
 
 
Table I.3 - Results from DLS analysis for NM-100 in the culture medium for concentrations 3.2, 32 and 240 µg/mL 
at 0, 24, 48 hours and 7 days. 
 
  Concentration 3.2 µg/mL Concentration 32 µg/mL Concentration 240 µg/mL 
Time PdI±SD Z Average±SD PdI±SD Z Average±SD PdI±SD Z Average±SD 
0 hours 0.39±0.08 225.2±29.9 0.21±0 319.45±2.55 0.20±0.04 320.57±30.97 
24 hours 0.475±0.10 255.8±37.8 0.25±0.03 317.15±56.55 0.14±0.01 246.5±3.6 
48 hours 0.44 267.9 0.25 250.07 0.22 291.5 
7 days 0.51 367.8 0.58 363.8 0.21 247.4 
 
  
  Concentration 3.2 µg/mL Concentration 32 µg/mL Concentration 240 µg/mL 
Time PdI±SD Z Average±SD PdI±SD Z Average±SD PdI±SD Z Average±SD 
0 hours 0.71±0.01 125.48±1.01 0.23±0.03 288.15±2.19 0.17±0.01 293.2±23.33 
24 hours 0.3±0.01 169.4±24.32 0.23±0 241.6±32.24 0.18±0.04 258.05±19.16 
48 hours 0.23 167.1 0.19 222 0.15 250.7 
7 days ND ND 0.37 298.7 0.41 462.5 
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Table I.4 - Results from DLS analysis for NM-220 in the culture medium for concentrations 3.2, 32 and 240 µg/mL 
at 0, 24, 48 hours and 7 days. 
  Concentration 3.2 µg/mL Concentration 32 µg/mL Concentration 240 µg/mL 
Time PdI±SD Z Average±SD PdI±SD Z Average±SD PdI±SD Z Average±SD 
0 hours 0.63±0.08 26.62±2.32 0.58±0.0 88.94±1.6 0.2±0.02 138.51±0.09 
24 hours 0.70±0.12 28.54±4.95 0.42±0.17 145.95±56.75 0.19±0.01 139.2±1.8 
48 hours 0.56 23.52 0.6 90.57 0.18 136.9 
7 days 0.97 39.29 0.6 111.1 0.22 117.5 
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ANNEX II- Cytotoxic Assays  
 
Table II.1 - Viability results obtained from MTT assay for NM-212, NM-101, NM-100 and NM-220. 
 
  NM-212 NM-101 NM-100 NM-220 
NM Concentration 
(µg/cm2) 
Mean±SD Mean±SD Mean±SD Mean±SD 
0 100 100 100  100  
1 91.94±6.64 107.06±11.47 103.71 ± 7.39 95.24 ± 10.32 
3 90.12±7.08 106.31±19.72 98.19 ± 7.63 95.24 ± 2.45 
10 103,30±3,96 108.13±12.98 91.35 ± 6.92 92.07 ± 11.93 
30 94.95±16.03 97.91±8.41 93.14 ± 25.62 88.94 ± 9.61 
75 102.12±7.37 92.41±10.51 95.16 ± 27.85 87.72 ± 27.75 
100 93.75±18.70 87.85±11.56 97.82 ± 10.96 91.69 ± 16.56 
SDS 0.01% 34.72±2.59 16.12*±21.20 5.24* ± 1..30 5.38* ± 0.99 
*- Significantly different (p≤ 0.05) from the negative control (Mann- Whitney U test) 
 
 
Table II.2 - Cellular proliferation study from clonogenic assay for NM-212. 
 
  NM-212 
NM Concentration 
(µg/cm2) 
Mean±SD 
0 1±0.15 
1 0.84±0.11 
3 0.76±0.09 
10 0.77±0.2 
30 0.69±0.1* 
75 0.63±0.21* 
100 0.56±0.28* 
MMC 0.00425 µg/mL 0.16±0.16** 
*-Significantly different (p≤ 0.05) from the negative control (Post-Hoc testes from One-Way ANOVA test); **- 
Significantly different (p≤ 0.05) from the negative control (t-Student test). 
 
 
Table II.3 - Replication indexes (RI and CBPI) obtained from CBMN assay for NM-212, NM-100 and NM-220. 
 
  NM-212 NM-100 NM-220 
  Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
NM Concentration 
(µg/cm2) 
CBPI RI CBPI RI CBPI RI 
0 1.96±1.83 100±0 1.91±0.02 100±0 1.87±0.00 100±0.00 
1 1.95±0.84 97.83±7.74 1.86±0.01 93.65±1.47 1.80±0.01 92.09±0.86 
3 1.9±1.41 92.82±2.54 1.89±0.02 97.90±1.75 1.81±0.00 92.72±0.46 
10 1.94±0.5 96.87±5.58 1.86±0.01 94.47±0,77 1.82±0.02 94.33±2.18 
30 1.93±7.94 96.36±3.17 1.84±0.01 91.73±1.1 1.73±0.03 84.36±3.09 
75 1.95±8.43 97.59±2.61 NA NA 1.75±0.02 85.44±2.81 
100 1.99±0.03 102.6±3.31 NA NA 1.73±0.00 83.34±0.36 
MMC 0.3 µg/ml 1.37±0.01* 38.59±1.02* 1.45±0.01 49.21±1.01 1.46±0.02 52.37±2.52 
*- Significantly different (p≤0.05) from the negative control (Mann-Whitney U test); NA- not applicable.  
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ANNEX III- Genotoxicity Assays 
 
 
Table III.1 - Results from CBMN assay for NM-212, NM-100 and NM-220. 
 
  MNBNC/1000 BC 
  NM-212 NM-100 NM-220 
NM Concentration 
(µg/cm2) 
Mean±SD Mean±SD Mean±SD 
0 2.49±1.29 2.00±2.83 1.00±0.00 
1 1.25±1.26 1.50±2.12 3.00±2.00 
3 2.25±1.50 1.00±0.00 1.50±1.50 
10 2.00±1.83 0.50±0.71 2.00±1.00 
30 1.98±0.84 0.00±0.00 2.50±1.50 
75 1.00±1.41 NA 1.00±1.00 
100 0.25±0.50* NA 2.00±0.00 
MMC 0.3 µg/mL 21.96±8.43* 12.50±12.02* 14.67±1.38* 
*- Significantly different (p≤0.05) from the negative control (Fisher's Excat Test). 
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Table III.2 - Results from comet assay, after 3 hours of exposure, with and without FPG, for NM-212, NM-101, NM-100 and NM-220. 
 
  NM-212 NM-101 NM-100 NM-220 
  No FPG FPG No FPG FPG No FPG FPG No FPG FPG 
NM Concentration 
(µg/cm2) 
Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
0 7.74±2.78 6.62±4.74 6.82±2.75 9.47±1.95 6.04±0.10 11.36±0.19 4.89±0.75 7.96±0.29 
1 10.20±4.62 9.88±4.88 11.39±5.11 15.67±11.29 12.91±0.59 14.15±3.5 8.62±1.72 9.67±4.64 
3 9.01±7.5 7.74±2.94 9.35±2.8 14.37±4.68 12.06±2.50 22.83±0.64 9.52±1.73 14.07±5.67 
10 9.07±4.23 10.01±6.15 8.69±1.2 8.05±6.38 16.02±1.27 24.51±0.51* 6.86±1.23 13.95±2.03 
30 10.59±4.95 9.68±8.58 14.07±4.63 30.97±5.42* 25.06±1.15* 31.2±6.96* 8.71±1.24 7.64±2.11 
75 10.06±8.51 17.42±11.46 19.83±5.95* 41.31±3.98* 33.06±1.20* 30.5±4.53* 7.72±1.45 11.66±3.38 
100 11.62±5.9 18.09±18.14 17.73±3.59* 46.45±7.23* 40.85±6.27* 42.72±0.14* 6.94±1.95 9.66±1.18 
EMS 11.71±12.55 43.65±3.33** 28.19±5.66** 49.66**±4.41 44.71±3.48** 67.86±4.36** 39.6±7.36* 60.37±18.71 
*- Significantly different from the negative control (Post Hoc from One-Way ANOVA test). **- Significantly different from the negative control (t-Student test). 
 
Table III. 3- Results from comet assay, after 3 hours of exposure, with and without FPG and respective significant p values (control versus treated culture) for 
NM-101 and NM-100. 
  NM-101 NM-101 NM-100 NM-100 
  No FPG FPG No FPG  FPG No FPG FPG No FPG FPG 
NM 
Concentration 
(µg/cm2) 
Mean±SD Mean±SD p value p value Mean±SD Mean±SD p value p value 
0 6.82±2.75 9.47±1.95 NS NS 6.04±0.10 11.36±0.19 NS NS 
1 11.39±5.11 15.67±11.29 NS NS 12.91±0.59 14.15±3.5 NS NS 
3 9.35±2.8 14.37±4.68 NS NS 12.06±2.50 22.83±0.64 NS NS 
10 8.69±1.2 8.05±6.38 NS NS 16.02±1.27 24.51±0.51 NS p<0.001 
30 14.07±4.63 30.97±5.42 NS p<0.001 25.06±1.15 31.2±6.96 p<0.001 p<0.001 
75 19.83±5.95 41.31±3.98 p=0.003 p<0.001 33.06±1.20 30.5±4.53 p<0.001 p<0.001 
100 17.73±3.59 46.45±7.23 p=0.014 p<0.001 40.85±6.27 42.72±0.14 p<0.001 p<0.001 
EMS 28.19±5.66 49.66±4.41 p=0.001 p=0.064 44.71±3.48 67.86±4.36 p<0.001 p=0.001 
NS- Concentrations without significant p values. 
 
 
Table III.4 - Results from comet assay, after 24 hours of exposure, with and without FPG, for NM-212, NM-101, NM-100 and NM-220. 
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  NM-212 NM-101 NM-100 NM-220 
  No FPG FPG No FPG FPG No FPG FPG No FPG FPG 
NM Concentration 
(µg/cm2) 
Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD 
0 7.38±4.43 5.87±3 6.17±2.93 11.13±1.21 6.42±2.4 8.55±1.34 6.77±1.05 8.97±1.31 
1 10.55±4.47 8.46±1.31 7.25±3.2 13.02±8.53 11.16±4.63 12.04±1.44 11.74±1.92 11.03±1.83 
3 6.04±2.48 9.05±4.72 7.69±1.46 11.83±5.05 11.62±0.64 12.78±2.32 11.31±6.92 13.55±2.87 
10 9.69±4.72 9.2±4.98 9.02±4.12 13.66±6.12 18.11±3.09* 26.06±4.28* 12.31±2.39 18.98±4.17 
30 12.89±7.81 8.82±4.72 12.15±2.79 28.17±6.12* 26.68±3.99* 30.95±2.18* 6.21±1.3 15.18±2.57 
75 10.59±6.35 7.87±3.13 15.68±1.34* 39.46±5.5* 32.48±4.16* 36.63±4.89* 12.84±2.46 10.99±1.82 
100 14.57±3.51 7.51±0.56 27.45±4.27* 39.13±8.42* 36.79±3.2* 38.11±7.68* 13.63±1.56 12.9±5.84 
EMS 19,98**±6 37.83**±11.09 28.06±4.76** 49.66±4.41** 39.93±4.66** 67.86±4.36** 34.24±1.85 59.78±11.05 
*- Significantly different from the negative control (Post Hoc from One-Way ANOVA test). **- Significantly different from the negative control (t-Student test) 
 
 
 
Table III. 5- Results from comet assay, after 24 hours of exposure, with and without FPG and respective significant p values (control versus treated cultures) for NM-101 and NM-
100. 
 
  NM-101 NM-101 NM-100 NM-100 
  No FPG FPG No FPG  FPG No FPG FPG No FPG FPG 
NM 
Concentration 
(µg/cm2) 
Mean±SD Mean±SD p value p value Mean±SD Mean±SD p value p value 
0 6.17±2.93 11.13±1.21 NS NS 6.42±2.4 8.55±1.34 NS NS 
1 7.25±3.2 13.02±8.53 NS NS 11.16±4.63 12.04±1.44 NS NS 
3 7.69±1.46 11.83±5.05 NS NS 11.62±0.64 12.78±2.32 NS NS 
10 9.02±4.12 13.66±6.12 NS NS 18.11±3.09 26.06±4.28 p=0.001 p<0.001 
30 12.15±2.79 28.17±6.12 NS p=0.012 26.68±3.99 30.95±2.18 p<0.001 p<0.001 
75 15.68±1.34 39.46±5.5 p=0.004 p<0.001 32.48±4.16 36.63±4.89 p<0.001 p<0.001 
100 27.45±4.27 39.13±8.42 p<0.001 p<0.001 36.79±3.2 38.11±7.68 p<0.001 p<0.001 
EMS 28.06±4.76 49.66±4.41 p<0.001 p=0.003 39.93±4.66 67.86±4.36 p<0.001 p<0.001 
NS- Concentrations without significant p values. 
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ANNEX IV- Clonogenic Assay 
 
Figure IV. 1-  Results of the clonogenic assay after 7 days cells exposure to NM-100. 
 
 
 
 
Figure IV. 2- Results of the clonogenic assay after 7 days cells exposure to NM-101 (Santos 
(2015)). 
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